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ABSTRACT
Marineosins A and B are two spiroaminal-ring containing tripyrrole compounds
isolated from the marine actinomycete, Streptomyces CNQ-617, and were found
to possess potent and selective cytotoxic activity against leukemia and
melanoma. Marineosins belong to the prodiginines class of natural products,
examples of which are undecylprodiginine and streptorubin B. Unlike
marineosins, prodiginines structures are characterized by the presence of fully
conjugated tripyrrole nucleus linked to an alkyl chain (that lacks any oxygen).
Cyclic prodiginines arise from an oxidative cyclization of the alkyl chain onto the
tripyrrole, a step catalyzed by Rieske-oxygenase like enzymes such as RedG.
The biosynthesis of prodiginines is directed via the red gene cluster. The unique
structural differences between marineosin and other prodiginines spurred the
proposal of a number of hypotheses for its biosynthesis, none of which have
been experimentally tested. A red gene cluster homolog which has only one
extra dehydratase-encoding gene; marA has been identified from the genomic
library of Streptomyces CNQ-617, and the identified cluster was proposed to
direct the biosynthesis of marineosin. In this study, the identified putative gene
cluster was expressed in the heterologous host, S. venezuelae, and marineosin
production in the new strain; JND2 was confirmed via LC/MS and 1H-NMR. The
new engineered strain also produces a myriad of marineosin related shunt
metabolites and pathway intermediates. This study hence presents the first
identified gene cluster proved to direct the biosynthesis of marineosin; the mar
i

gene cluster and proves that the cloned cluster encodes most, if not all the
enzymes required to direct the biosynthesis of marineosin.
Deletion of the Rieske-oxygenase encoding gene; marG (a RedG homolog) from
the mar gene cluster led to the accumulation of 2-hydroxyundecylprodiginine;
G410 with an m/z 410.28 and molecular formula C25H35O2N3. This data proves
that MarG is not responsible for the introduction of the spiromaminal ring oxygen
on the alkyl chain, but is required for catalyzing macrocyclic ring formation
between C-8 and C-9 of G410. Undecylprodiginine production in marG deletion
mutant was not observed which indicates that undecylprodiginine is likely not an
intermediate along the pathway for marineosin biosynthesis, and indicates that
the spiroaminal ring oxygen is introduced early in the pathway, possibly due to
the incorporation of a 3-hydroxy-butyric acid starter unit.
Deletion of the dehydratase-encoding gene; marA, from the mar gene cluster led
to the accumulation of compounds JN408 and JN422 with m/z 408.26 and
422.24 and molecular formulae C25H33O2N3, and C25H31O3N3, respectively.
Purification and structure elucidation of JN408 proves it to be an oxidized
marineosin analog which has fully aromatic tripyrrole rings while; purification and
structure elucidation of JN422 proves it to be a 9-keto-JN408 derivative. Both
JN408 and JN422 compounds have a spiroaminal ring which indicates that MarA
does not catalyze spiroaminal ring formation but catalyzes the reduction of
pyrrole ring B of JN408 to yield marineosin. Therefore, we are proposing that
MarA acts as a dehydrogenase, rather than a dehydratase. We are proposing
ii

that the intramolecular spiroaminal ring formation is catalyzed by either MarG or
occurs non-enzymatically. JN422 is a shunt metabolite produced due to
promiscuous activity of either MarG or an unidentified oxidase in the mar cluster,
possibly MarT.
From the data generated in this study, we present the first experimentally
supported pathway for the biosynthesis of marineosin and the opportunity to
generate novel compounds with potentially useful biological activities.
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1. INTRODUCTION
1.1 NATURAL PRODUCTS AND STREPTOMYCES
Secondary metabolites or natural products are small organic molecules that are
naturally produced by plants, fungi, algae, soft corals, sponges and bacteria.
Although natural products do not play an explicit role in the vegetative growth of
the producing organism, many scientists believe that secondary metabolites play
a role in increasing the survivability and the adaptation of the producer organism
in its complex environment by eliminating competing organisms [1], abstracting
necessary metals from the environment [2], or mediating cell to cell contact [3].
Natural products possess a wide variety of clinical and pharmacological
applications where they serve as antibiotics such as erythromycin A (1),
antifungals such as amphotericin B (2), immunosuppressant such as rapamycin
(3), hypolipidemics such as lovastatin (4) and anticancer drugs such as
doxorubicin (5) compounds (Figure 1). Natural products account for about 47% of
the drugs approved by the FDA for treatment of cancer [4] and natural products
isolated from the genus; Streptomyces accounts for about two thirds of the
world’s antibiotics [5].
Streptomyces is a Gram-positive actinobacteria that can be found in terrestrial or
marine environments and is characterized by high G+C percent DNA as
compared to other Gram-positive bacteria such as Bacillus and Streptococcus
[6].
1

Figure 1: Examples of Natural Products
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Unlike other bacteria, Streptomyces colonies consist of differentiated cells and
the life cycle [6] begins when a spore germinates one or more germ tubes that
develop vegetative or substrate mycelia. Due to nutrition requirements, the
vegetative mycelia branches out to form aerial mycelia that will be later
compartmentalized via sporulation septa to form new spores [6].

Figure 2: Life Cycle of Streptomyces lividans. Scanning electron micrographs showing a.
vegetative mycelia, b. vegetative mycelia branching into aerial mycelia, c. sporulation septa is
formed in the aerial hyphae, d. spore chains. The figure is adapted from reference 6.

The importance of Actinomycetes to biomedical research and drug discovery
comes from the ability of these bacteria to produce enormous numbers of
3

structurally diverse antibiotics that by 2002, it was estimated that 8700 antibiotics
were isolated from terrestrial Streptomyces versus 7800 antibiotics from all other
bacteria and fungi combined [7].

1.2 BIOSYNTHESIS OF NATURAL PRODUCTS
Natural products are biosynthesized via complex dedicated enzymatic machinery
encoded by genes adjacent to each other in the organism’s genome to form a
biosynthetic gene cluster. The dedicated biosynthetic machinery utilizes common
primary metabolites such as dicarboxylic acid thioesters, fatty acids, sugars and
amino acids. The structural diversity and complexity of natural products is best
manifested in two classes of natural products: polyketides and non-ribosomal
peptides synthesized by polyketide synthases (PKS) and non-ribosomal peptide
synthetases (NRPS), respectively. A type I PKS (Figure 3) is a megasynthase or
a multifunctional multienzyme complex that catalyzes multiple head to tail
decarboxylative condensations or Claisen condensation of dicarboxylic acid
thioesters to form a polyketide in a manner analogous to fatty acid biosynthesis.
There are four main domains (Figure 3) required for the biosynthesis of a
polyketide: acyltransferase (AT), acyl carrier protein (ACP), ketide synthase (KS),
and a thioesterase (TE) domain. The biosynthesis of a polyketide usually starts
with the loading of a starter unit such as acetyl, propionyl, or butryl-CoA onto the
N-terminal ACP domain via the adjacent AT domain. The chain is then elongated
by 2 carbons via a decarboxylative condensation between the tethered acyl-ACP
4

and one dicarboxylic acid thioester extender unit molecule such as malonyl-CoA
in a reaction catalyzed by the KS domain. After several cycles of elongation, the
polyketide is released from the PKS megasynthase by the TE domain to yield
either a linear or cyclic product (Figure 3).

Figure 3: The Modular PKS of Pikromycin, an Example of Type I PKS

In type I PKS systems, an additional ketoreductase (KR) domain (module 1,
Figure 3) can reduce a keto group into a hydroxyl group and then a dehydratase
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(DH) domain (module 2, Figure 3) can catalyze double bond formation via the
elimination of water from the polyketide. An enoyl-reductase (ER) domain
(module 4, Figure 3) can then fully reduce the growing polyketide [8], [9]. It
should be noted that for the ACP domain to be functional, it has to be posttranslationally modified from the inactive apo form to the active holo form by a
separate enzyme called phosphopantetheinyltransferase (PPTase). PPTase
transfers a 4’-phosphopantetheine group from Coenzyme A (CoA) to a highly
conserved serine residue in the ACP domain. The long and flexible
phosphopantetheine arm provides a terminal sulfhydryl group that carries the
growing polyketide chain via a thioster bond and transfers the tethered polyketide
chain among the PKS domains. The biosynthetic gene clusters usually encode
other enzymes that do not participate in the biosynthesis but rather play a
regulatory role and/or confer resistance to the natural product in question to
protect the producing organism [1], [10]. Examples of polyketides biosynthesized
via type I PKS are: pikromycin (Figure 3), erythromycin (1) (Figure 1) antibiotics
and the cholesterol lowering agent; lovastatin (4) (Figure 1).

1.3 STUDY OF NATURAL PRODUCTS BIOSYNTHESIS
The proven clinical and economic value of natural products has fueled the search
for tools to aid in understanding their biosynthesis as well as enabling the
biosynthetic engineering of analogs of better pharmacological activity, improved
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bioavailability or reduced toxicity. Some of the tools to study the biosynthesis of a
natural product of microbial origin are outlined below:
i) Isotope tracer studies:
As mentioned in section 1.2, natural products are made of building blocks that
can be provided through primary metabolism such as fatty acids and amino
acids. Therefore, feeding the growing microorganism with stable isotope-labeled
precursors can be used to identify the general biosynthetic origin of a natural
product since the incorporation of the isotope-labeled precursor in the natural
product skeleton results in unique coupling and labeling patterns [11]. Such
incorporation patterns can suggest the involvement of a particular pathway in the
biosynthesis of the secondary metabolite such as the shikimic acid pathway
involved in the biosynthesis of hygromycin from Streptomyces hygroscopicus [12]
and phoslactomycin from Streptomyces sp. strain HK803 [13]. Stable isotopelabeling can even lead to the discovery of new pathways such as the discovery of
the non-mevalonate pathway involved in the biosynthesis of isoprenoids after
feeding [13C1]-glucose isotopomers and [13C]-acetate isotopomers to eubacteria
producing the isoprenoids, hopanoids [14].

ii) The construction, characterization and screening of genomic libraries:
A genomic library for a microorganism can be generated from its total or genomic
DNA (gDNA) using cosmid, fosmid, or BAC vectors depending on the insert size
and whether heterologous expression of a particular gene cluster is required [15],
7

[16]. The genomic libraries can then be screened for the gene cluster presumed
to be responsible for the biosynthesis of a particular secondary metabolite using
specific probes. The probes are usually short radio-labeled DNA sequences
homologous to gene(s) specific to the cluster required and are amplified from the
organism’s gDNA using degenerate primers using PCR. For example; the use of
the chcA gene probe for the screening of the genomic library of Streptomyces sp.
strain HK803 to identify the gene cluster encoding the biosynthesis of
phoslactomycin [13], [17]. More recent screening techniques include the use of
non-radioactive probes, antibodies, and PCR methods [18].

iii) The heterologous expression of gene clusters:
Heterologous expression of a biosynthetic gene cluster seeks the production of
the natural product in question in an organism other than the original producer by
introducing the genes presumed to be involved in the biosynthesis to the new
organism. When successful, heterologous expression provides unequivocal
evidence of the responsibility of the gene cluster expressed in the biosynthesis of
the natural product in question. It also indicates that all the genes required for the
biosynthesis are present in the cluster as well as any regulatory and resistanceconferring genes. Choosing E. coli or Streptomyces species as heterologous
hosts allow rapid genetic manipulations of the gene cluster via Red/ET-mediated
recombination [19], [20], to further study the biosynthesis of the compound and
facilitates engineering of other analogs. Heterologous expression can also
8

facilitate the over-expression of pathway-specific regulatory genes and therefore
enhance the production of the secondary metabolite in question [21], [22]. One of
the techniques employed in the heterologous expression of a particular gene
cluster in Streptomyces involves modifying the BAC or cosmid vector carrying the
cluster by including phage ΦC31 integration functions to allow for site-specific
integration of the pathway in the Streptomyces genome [23]. The presence of
oriT, an origin of transfer in the cosmid carrying the gene cluster facilitates DNA
mobilization between E.coli and Streptomyces via conjugation [24] and the
presence of an antibiotic resistance-conferring gene or an antibiotic resistance
marker such as tet; which encodes resistance to tetracycline, would allow for
selection of exconjugants actively expressing the gene cluster [25]. The use of E.
coli-Streptomyces Artifictial Chromosomes (ESAC) allows for the integration of
DNA fragments > 100 kb in Streptomyces [26], [27].

iv) Gene deletion and/or replacement studies:
The deletion or replacement of individual genes along a biosynthetic pathway
can be used to probe the role of the deleted genes in the biosynthesis in vivo. In
this process, a particular gene can be completely deleted or replaced with
another gene that confers resistance to a certain antibiotic such as ampicillin via
PCR-targeted recombination or Red/ET-mediated recombination [16], [19], [20].
Gene deletion or replacement generates a mutant inefficient or totally incapable
of producing the natural product in question. Comparing the metabolite pool of
9

the resultant mutant with the wild type organism pinpoints any intermediates,
precursors or shunt metabolites accumulated due to the gene deletion and thus
proposes a role for that gene in the biosynthesis of the natural product. Gene
deletion experiments can be followed by complementation of the mutant strain
with

either

the

needed

precursor

or

a

precursor

analog

(chemical

complementation); or with an expression plasmid carrying the deleted gene or
another gene homolog (genetic complementation) to either rescue the production
of the natural product itself or produce an engineered analog.

v) Protein expression of individual genes:
In order to assess substrate specificity in vitro and to provide a detailed kinetic
analysis of individual enzymes participating in the biosynthesis of a certain
natural product, their respective genes can be expressed in a heterologous host
such as E.coli, followed by enzyme purification. A variety of high-level expression
vectors are now available to allow gene expression under the influence of the
bacteriophage T7 polymerase promoter [28]. The development of the HisTag
technology allows the fusion of 6 histidine amino acid residues to either the N- or
C-terminal end of the expressed protein which facilitates the purification of the
recombinant protein by affinity chromatography using metal chelation resins [29].
After purification, the proteins can be used in a number of assays depending on
the reactions they catalyze to monitor the substrate specificity as well as the rate
by which they catalyze their reactions. The in vitro assays using the expressed
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enzymes provide greater and more valuable insight into the mechanistic role of
the individual enzyme in the biosynthetic process as a whole.

1.4 PRODIGININES FAMILY OF NATURAL PRODUCTS
1.4.1 History and Significance
Prodiginines (also known as prodigiosins) are tripyrrole red-colored compounds
(Figure 4) isolated from Serratia marcescens, Streptomyces coelicolor A3(2),
Hahella chejuensis and many other terrestrial and marine microorganisms [30].
These compounds are thought to be responsible for a number of prodigious
miracles linked to the appearance of blood on bread and other starchy foods in
the middle ages [31].

Prodiginines can either be linear, like prodigiosin (6)

(Figure 4) and undecylprodiginine (7) (Figure 4), or cyclic like streptorubin B (8)
(Figure 4), metacycloprodigiosin (9) (Figure 4) and marineosins (10 and 11)
(Figure 4). Prodiginines have excellent cytotoxic activity against a wide variety of
cancer cell lines via inducing apoptosis [32], facilitating oxidative DNA cleavage
by intercalating Cu (II) and DNA [33], and by other mechanisms. Due to their
unique and selective mode of action as anticancer compounds, GX15-070 or
obatoclax (12) (Figure 4); a synthetic prodiginine analog is in phase 1 and 2
clinical trials by Gemin-X pharmaceuticals [34]. Prodiginines also possess potent
immunosuppressant activity via inhibition of T lymphocytes-mediated antibody
response [35–37] which spurred the synthesis of many prodiginine analogs of
which; PNU-156804 (13) (Figure 4) was found to be the most potent with unique
11

immunosuppressant activity, minimal cytotoxicity and improved therapeutic index
[36], [37].

Prodiginines also possess strong antibacterial and antimalarial

activities [38].
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Figure 4: Example of Prodiginines

13

1.4.2 Biosynthesis:
The biosynthesis of undecylprodiginine (7) (Figure 4), a linear prodiginine
isolated from S. coelicolor A3(2), was initially probed using isotope labeling
studies in the early 1970s. It has now been shown that undecylprodiginine (7)
(Figure 4) is biosynthesized via a bifurcated pathway (Figure 5) that involves the
condensation of 2 subunits; 2-undecylpyrrole (2-UP) (Figure 4, 10) and 4methoxy-[2, 2’-bipyrrole]-5-carboxaldehyde (MBP) (Figure 4, 9) subunits [39–42].
Feeding of stable isotope-labeled precursors showed that the 2-UP subunit
(Figure 4, 10) is derived from seven acetate molecules and one L-glycine while
the MBP subunit (Figure 4, 9) is derived from one molecule of acetate, one Lproline, one L-serine and a methyl group derived from L-methionine amino acid.

Figure 5: The bifurcated pathway leading to the biosynthesis of undecylprodiginine and
streptorubin B in S. coelicolor A(3)2
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The gene cluster responsible for the biosynthesis of undecylprodiginine and
streptorubin B (Figure 4, 2 and 3 respectively) in S. coelicolor A(3)2, known as
the red cluster was cloned and expressed in the heterologous host Streptomyces
parvulus in 1990 [43], [44]. The complete sequencing of the red cluster was
achieved in 2002 as part of the genome sequencing project of S. coelicolor A(3)2
[45]. The red cluster (Figure 6) is arranged in four transcription units consisting of
23 genes two of which are regulatory; redD and redZ (Figure 6). Most of the
genes involved in the biosynthesis of undecylprodiginine and streptorubin B were
characterized via gene deletion and feeding experiments, as well as some
enzymatic studies. The red genes were assigned as either involved in the
biosynthesis of the MBP subunit (Figure 4, 9) or the 2-UP subunit (Figure 4, 10).
The genes involved in the biosynthesis of the MBP subunit (9) were found to be
redM, O, W, X, N, V, U and redI while the genes involved the 2-UP subunit (10)
biosynthesis are redP, R, Q, J, L, J and redK. The condensation of the two
subunits to form undecylprodiginine is catalyzed by redH, while the cyclization of
undecylprodiginine into streptorubin B is catalyzed by redG [46–51].

Figure 6: The red gene cluster responsible for the biosynthesis of undecylprodiginine and
streptorubin B in S. coelicolor A(3)2. Red color is for regulatory proteins, green, genes
involved in the biosynthesis of the MBP subunit, dark blue, genes involved in the biosynthesis of
the 2-UP subunit, light blue, condensation of the MBP and 2-UP subunits, orange, genes involved
in oxidative cyclization, grey, genes encoding membrane proteins, black, genes encoding
hypothetical proteins.
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An outline of the biosynthesis is summarized below:
The biosynthesis of the MBP subunit (9): The biosynthesis of the MBP subunit
(Figure 5) starts with the activation of L-proline amino acid as an adenylate
intermediate by RedM which is then passed over to the PCP (peptidyl carrier
protein); RedO. The tethered L-proline is then oxidized by RedW to form pyrrolyl2-carboxyl-S-RedO which is extended by 2 carbons via a decarboxylative
condensation of malonyl-CoA with pyrrolyl-2-carboxyl-S-RedO catalyzed by
RedX; a ketosynthase (KS) (Figure 5). The resultant pyrrolyl-β-ketothioester is
condensed with L-serine amino acid residue with the release of CO2 in a reaction
catalyzed by the PLP-dependent α-oxoamine synthase (OAS) domain of RedN to
give 4-hydroxy-2,2’-bipyrrole-4-methanol (HBM). Methylation of HBM is catalyzed
by RedI; an S-adenosylmethionine (SAM)-dependent methyl transferase. The
post-translational phosphopantetheinylation of RedO and the two ACP domains
of RedN (to convert them from the apo- inactive form to the holo- active form) is
proposed to be catalyzed RedU [30], [48].
b. The biosynthesis of the 2-UP subunit (10): the biosynthesis of the dodecanoic
acid moiety (Figure 5) of the 2-UP subunit (10) of prodiginines portrays a great
level of interplay between fatty acid biosynthesis; a primary metabolic process
and secondary metabolism. As mentioned above, the 2-UP subunit (10) consists
of one L-glycine amino acid residue and seven acetate molecules arranged head
to tail in a manner analogous to fatty acid biosynthesis catalyzed by type II fatty
acid synthases (Fas/Fab enzymes). It is proposed that the biosynthesis of 2-UP
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(Figure 5) is initiated by RedP (a FabH homolog) which catalyzes the
decarboxylative condensation of one molecule of acetyl-CoA with malonyl-RedQ
(or malonyl-ACP) to yield 3-keto-butyryl-RedQ that will be fully reduced into
butyryl-RedQ via the FAS enzymes, since homologs of such enzymes are
completely absent from the red cluster. The resultant 3-keto-butyryl-RedQ is then
elongated by six malonyl-CoA extender units in a reaction catalyzed by RedR (a
FabF homolog). In each round of elongation, it is proposed that the acyl chain is
fully reduced by the aid of FAS enzymes to yield dodecanoyl-RedQ (Figure 5).
RedJ (a type II thioesterase) has been shown to hydrolyze the acyl chain of
RedQ to produce free dodecanoic acid which is the substrate for the multifunctional protein; RedL (Figure 5). RedL catalyzes one more round of acyl chain
elongation with malonyl-CoA to yield 3-ketomyristoyl-ACP which is then
condensed with L-glycine amino acid residue with the elimination of CO2 to
produce

4-keto-2-undecylpyrroline.

Finally,

RedK

reduces

4-keto-2-

undecylpyrroline into 4-hydroxyl-2-undecylpyrroline which spontaneously looses
H2O to yield the 2-UP subunit (Figure 5).
The two subunits, MBP (14) and 2-UP (15), are then condensed to yield
undecylprodiginine via RedH, which is proposed to do so by catalyzing an ATPdependent phosphorylation of the aldehyde oxygen of the MBP subunit (14),
which facilitates a nucleophilic attack by C5 of 2-UP (15) to yield
undecylprodiginine (7) [51]. The conversion of undecylprodiginine into the cyclic
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analog; streptorubin B (8) is mediated by RedG; a Fe2S2 Rieske oxygenase-like
enzyme [52].
1.5 MARINEOSINS, NEW UNDECYLPRODIGININE ANALOGS
1.5.1 Structure and discovery
Marineosins A and B (Figure 4) (10 and 11), are natural prodiginine analogs
isolated from the marine Streptomyces related strain; CNQ-617. Marineosin A
was found to have a potent cytotoxic activity against human colon cancer cell
line, HCT-116 with an IC50 of 0.5 μm. In the NCI-60 anticancer drug screening,
marineosin A had a broad anticancer activity with great selectivity against
leukemia and melanoma [53]. Structurally, marineosins are very distinct from
other prodiginines due to the presence of an unusual spiroaminal ring and a
reduced pyrrole ring. The biosynthetic origin of these structural differences is not
readily explained by the current understanding of the biosynthesis of prodiginines
(Figure 5) and the enzymes involved have not yet been identified.

1.5.2 Biosynthesis hypotheses
The potent anticancer activity of marineosin and its intriguing structure spurred
the proposal of a number of hypotheses to explain its biosynthesis. The first
hypothesis (Figure 7) was proposed by Fenical and co-workers in 2008 where,
they proposed that the MBP subunit normally biosynthesized in most
prodiginines is condensed with a 2-UP subunit analog; 2-keto-undec-3enylpyrrole to yield an enone-derivative of undecylprodiginine. A hetero-Diels18

Alder cyclization of the enone-undecylprodiginine intermediate would form the
tetrahydropyran and spiroaminal ring concomitantly [53] (Figure 7).

Figure 7: Fenical’s Hypothesis for the Biosynthesis of Marineosin. Fenical and co-workers
postulates the formation of enone-undecylprodiginine intermediate [53].

The above hypothesis was put to the test in the beginning of 2010 when Lindsay
and co-workers tried to synthesize marineosin using Fenical’s proposal [54].
Lindsay’s group synthesized the enone-undecylprodiginine intermediate and
attempted to produce marineosin through the hetero- Diels-Alder cyclization as
proposed by Fenical and co-workers but they were not successful [54]. Molecular
modeling studies by Lindsay and co-workers further revealed that the
intramolecular Diel-Alder reaction is energetically unfavorable and cannot be
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accomplished synthetically, however, they did not rule out the possibility that
such cyclization could be accomplished via enzymatic catalysis [54]. In late 2010,
another hypothesis for the biosynthesis of marineosin was postulated by Snider
and co-workers [55]. Snider’s hypothesis involves the formation of a macrocyclic
free radical (Figure 8) in a reaction catalyzed by a RedG-analog. The macrocyclic
free radical will be hydroxylated by the same proposed RedG-analog to form a
macrocyclic alcohol intermediate which undergoes a number of hydride shifts to
yield marineosins A and B [55].
It should be noted that there is no experimental evidence supporting either of the
hypotheses proposed by either Fenical’s group or Snider’s group. The enoneundecylprodiginine intermediate postulated by Fenical’s group was never isolated
and the enzymes required for its biosynthesis cannot be determined from our
current understanding for the biosynthesis of prodiginines. Though appealing,
Snider’s group’s hypothesis is not well supported by the current theories of action
of RedG homologs in the cyclization of prodiginines [52]. Therefore, the
identification of the gene cluster involved in the biosynthesis of marineosin is
necessary to provide an experimentally supported proposal for the biosynthesis
of marineosin.
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Figure 8: Snider’s Hypothesis for the Biosynthesis of Marineosin. Snider and co-workers
postulates the formation of a macrocyclic free radical that undergoes a number of hydride shifts
mediated by a RedG homolog [55].
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1.5.3 The identification of a hypothetical gene cluster
A SuperCos1 genomic library of Streptomyces CNQ-617 (marineosins-producing
strain) was constructed in E.coli by Reynolds and co-workers (unpublished data).
Screening of the genomic library for a red cluster homolog was performed using
a
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P-labelled probe generated by PCR amplification of a redW homolog named

marW using degenerate primers. RedW (Figure 5) starts the biosynthesis of
prodiginines by catalyzing the oxidation of L-proline into pyrroline, a committed
step in the biosynthesis of the MBP subunit (Figure 4) (14) of prodiginines [48]. A
RedW homolog is proposed to be essential for the biosynthesis of marineosin.
Cosmids positive for marW were further screened using a
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P-labelled probe

generated by PCR amplification of a redG homolog named marG using
degenerate primers. RedG (Figure 5) is a Rieske-oxygenase that culminates the
biosynthesis of streptorubin B (Figure 4) (8), a cyclic prodiginine analog by
catalyzing the cyclization of the acyl chain of undecylprodiginine (Figure 4) (7)
[52]. A RedG homolog is also proposed to be essential for the biosynthesis of
marineosin. The screening of the genomic cosmid library of Streptomyces CNQ617 using redW and redG homologs led to the identification of the cosmid 8A7
that carries the entire gene cluster proposed to be involved in the biosynthesis of
marineosin; a putative mar cluster together with about 6 kbp of DNA, apparently
encoding primary metabolic genes (unpublished data). Shotgun sequencing of
the putative mar cluster revealed a gene assembly almost identical to that of the
red cluster (Figure 9) with the presence of only one extra gene; marA. The MarA
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enzyme shares ~ 56% identity to a monoamine oxidase C (Mao C) like
dehydratase from Streptomyces hygroscopicus and was therefore annotated as
a dehydratase.

Figure 9: A comparison between the red gene cluster and the putative mar cluster. The mar
cluster (bottom panel) compared to the red gene cluster (top panel). Red color is for regulatory
proteins, green, involved in the biosynthesis of the MBP subunit, dark blue, involved in the
biosynthesis of the 2-UP subunit, light blue, condensation of the MBP and 2-UP subunits, orange,
oxidative cyclization, yellow, dehydratase, grey, membrane protein, black, hypothetical proteins.

The marA gene is proposed to be involved in the biosynthesis of the
tetrahydropyran ring while another gene, marG is proposed to catalyze the
reductive cyclization of the acyl chain of marineosin. MarG shares a 65% identity
to its red cluster counterpart RedG. The striking degree of homology among the
putative mar genes and their red genes counterparts (Table 1) together with the
abundance of the red cluster in several terrestrial and marine organisms raises
two major concerns. The first is whether or not the identified gene cluster is truly
responsible for the biosynthesis of marineosin and not another prodiginine
analog. The second is whether or not an extra tailoring enzyme is required for the
biosynthesis of marineosin which is not included in the 8A7 cosmid.
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Table 1: A comparison between the genes of the putative mar cluster and its red
counterparts:

MarD

RedD, a TetR family transcriptional regulator, Streptomyces griseus. Identities =
150/264 (56%), Positives = 181/264 (68%)

MarX

RedX, Streptomyces coelicolor A3(2), a polyketide synthase. Identities = 79/987
(58%), Positives = 675/987 (68%)

MarW

RedW, Streptomyces coelicolor A3(2), an acyl-CoA dehydrogenase. Identities =
304/388 (78%), Positives = 332/388 (85%)

MarY

RedY, Streptomyces coelicolor A3(2), unknown function. Identities = 60/104 (57%),
Positives = 73/104 (70%)

MarZ

RedZ, Streptomyces coelicolor A3(2), a response regulator. Identities = 111/206
(53%), Positives = 149/206 (72%)

MarV

RedV, Streptomyces coelicolor A3(2), unknown function. Identities = 192/350 (54%),
Positives = 230/350 (65%)

MarU

RedU, Streptomyces coelicolor A3(2), hypothetical protein. Identities = 146/246
(59%), Positives = 169/246 (68%)

MarT

RedT, Streptomyces coelicolor A3(2), hypothetical protein. Identities = 181/278
(65%), Positives = 211/278 (75%)

MarR

RedR, Streptomyces coelicolor A3(2), 3-oxoacyl-[acyl-carrier-protein] synthase II.
Identities = 181/278 (65%), Positives = 211/278 (75%)
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MarQ

RedQ, Streptomyces coelicolor A3(2), acyl carrier protein. Identities = 55/80 (68%),
Positives = 62/80 (77%)

MarP

RedP, Streptomyces coelicolor A3(2), 3-oxoacyl-(acyl carrier protein) synthase III.
Identities = 212/286 (74%), Positives = 239/286 (83%)

MarO

MarN

MarM

RedO, Streptomyces coelicolor A3(2), putative peptidyl carrier protein. Identities =
63/87 (72%), Positives = 71/87 (81%)

RedN, Streptomyces coelicolor A3(2), 8-amino-7-oxononanoate synthase. Identities =
465/641 (72%), Positives = 515/641 (80%),

RedM, Streptomyces coelicolor A3(2), peptide synthase. Identities = 368/529

(69%), Positives = 408/529 (77%)

MarL

RedL, Streptomyces coelicolor A3(2), polyketide synthase. Identities = 1095/1822
(60%), Positives = 1258/1822 (69%)

MarK

RedK, Streptomyces coelicolor A3(2), oxidoreductase. Identities = 243/346 (70%),
Positives = 280/346 (80%)

MarJ

RedJ, Streptomyces coelicolor A3(2), thioesterase. Identities = 164/252 (65%),
Positives = 180/252 (71%)

MarI

RedI, Streptomyces coelicolor A3(2), methyltransferase. Identities = 248/346 (71%),
Positives = 291/346 (84%)
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MarH

RedH, Streptomyces coelicolor A3(2), phosphoenolpyruvate-utilizing enzyme.
Identities = 642/916 (70%), Positives = 736/916 (80%)

MarG

RedG, Streptomyces coelicolor A3(2), oxidase. Identities = 218/334 (65%), Positives
= 269/334 (80%)

MarE

RedE, Streptomyces coelicolor A3(2), a hypothetical protein. Identities = 221/284
(77%), Positives = 248/284 (87%)

MarA

Monoamine oxidase C (MaoC) like dehydratase, Streptomyces hygroscopicus.
Identities = 85/151 (56%), Positives = 111/151 (73%)

1.6 SPECIFIC AIMS OF CURRENT RESEARCH
Up to date, the total chemical synthesis of marineosins is still incomplete [54],
[55]. There is no experimental evidence supporting the biosynthetic hypotheses
provided by either Fenical’s or Lindsley’s group and there is also no experimental
evidence that the gene cluster identified by Reynolds and co-workers is indeed
responsible for the biosynthesis of marineosin. The objective of the present
research is to investigate the key steps leading to the biosynthesis of marineosin
and to provide an experimentally supported proposal for its biosynthesis which
paves the road for the directed biosynthesis of marineosin analogs.
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This objective will be achieved through the following specific aims:

1) Determination of the role played by the putative gene cluster identified by
Reynolds and co-workers in the biosynthesis of marineosin or other prodiginine
analogs via expression in a heterologous host.

2) Probing the role of marG, encoding a Rieske oxygenase in the biosynthesis of
marineosin, via gene replacement experiments followed by characterization and
structure elucidation of the accumulated intermediates/shunt metabolites
accumulated using mass spectrometry and NMR.

3) Probing the role of marA, encoding a dehydratase potentially involved in the
biosynthesis of marineosin, via gene replacement experiments followed by
characterization and structure elucidation of the intermediates/shunt metabolites
accumulated using mass spectrometry and NMR.

4) Provide a proposal for the biosynthesis of marineosin that is experimentally
supported by the genetic replacement experiments and analysis of the metabolite
pool of the mutants generated in aims 2 and 3.
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2. THE IDENTIFICATION OF THE GENE CLUSTER RESPONSIBLE FOR THE
BIOSYNTHESIS OF MARINEOSIN: THE MAR CLUSTER.
2.1 SUMMARY
The screening of a SuperCos1 genomic library of Streptomyces CNQ-617 – the
marineosin producer, led to the identification of a cosmid clone that carries a
gene cluster that may direct the biosynthesis of marineosin. Gene annotation of
the putative mar cluster revealed a gene assembly similar to that of the red
cluster responsible for the biosynthesis of undecylprodiginine and streptorubin B
in S. coelicolor A3(2) (Figure 9) (Reynolds KA and co-workers, unpublished
work). Whether or not the identified gene cluster is indeed involved in the
biosynthesis of marineosin and whether it contains all the genes required for the
biosynthesis was never shown.
In this research, the SuperCos1 cosmid; 8A7 carrying the putative mar cluster
was expressed in the heterologous host; Streptomyces venezuelae and the
production of marineosin was confirmed via LC/UV, LC/UV-MS, Tandem mass
spectrometry and 1H-NMR. This study is the first direct evidence that the gene
cluster identified by Reynolds KA and co-workers is the one responsible for the
biosynthesis of marineosin and therefore, paves the road for a thorough
evaluation of the biosynthesis of marineosin and the engineering of marineosin
analogs via genetic and chemical complementation experiments. The newly
engineered strain Streptomyces venezuelae JND2 produces ~ 2 mg/L of
marineosin. The engineered strain also produces a number of marineosin
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analogs named JN408, JN422 and JN424 characterized with λmax 320 nm and
have [M+H]+ of m/z 408.28, 422.26, and 424.28 corresponding to molecular
formulae of C25H34O2N3, C25H32O3N3, and C25H34O3N3, respectively. These
compounds can be either pathway intermediates or shunt metabolites formed
due to accumulation of intermediates along the pathway.
In addition, other red-colored compounds with a λmax of 530 nm, were also
observed in the engineered strain. No tri-oxygenated red-colored compounds
were observed in S. venezuelae JND2 which suggests that additional oxidation
steps can occur later in the biosynthetic pathway, after loss of tripyrrole
conjugation. All observed compounds were absent from the control S.
venezueale acetone extract.
Based on the results of our studies, we propose four hypotheses that can explain
the biosynthetic origin of the spiroaminal moiety of marineosin.

2.2 INTRODUCTION
As described in section 1.5, marineosins A and B are two prodiginine analogs
isolated from a true marine Streptomyces with a strong and selective cytotoxic
activity against colon cancer and leukemia [53]. Marineosins are characterized by
the presence of an intriguing spiroaminal ring and a reduced pyrrole ring that
cannot be explained based on the bifurcated pathway established for the
biosynthesis of other prodiginines (Figure 5). Spiroaminal ring containing natural
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products are characterized by numerous biological activities such as the
immunosuppressant sanglifehrin (Figure 10), (16) [56] the antiviral crambescidin

Figure 10: Examples of spiroaminal compounds

alkaloids (Figure 10) (17 and 18) with activity against herpes simplex virus type1 (HSV-1) and human immunodeficiency virus (HIV) [57], [58] in addition to the
herbicidal hydantocidin (Figure 10) (19) [59]. Although the total synthesis of
spiroaminals was reported several times [55], [57], [59], [60], [61], [62], the
biosynthesis of this important class of natural products has been generally
neglected. The intriguing structure of marineosin spurred the proposal of
numerous hypotheses discussing its biosynthesis but no experimental data was
ever provided. A putative gene cluster similar to that of the red cluster
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responsible for the biosynthesis of undecylprodiginine and streptorubin B was
identified by Reynolds and co-workers after construction of a SuperCos1
genomic library of Streptomyces CNQ-617 however; its role in the biosynthesis of
marineosin was not established experimentally.

2.3 MATERIALS AND METHODS
2.3.1 Antibiotics, enzymes and chemicals
All antibiotics, chemicals and HPLC-grade solvents were purchased from SigmaAldrich (St. Louis, MO) unless otherwise stated. Primers for PCR were
purchased from Integrated DNA Technologies (Coralville, IA). Marineosin
standard was kindly provided by Dr. William Fenical (Scripps Institute of
Oceanography, San Diego, CA). Phusion high-fidelity DNA polymerase was
purchased from New England Biolabs (Ipswich, MA). Platinum High Fidelity
polymerase supermix was purchased from Invitrogen.

2.3.2 Bacterial strains and culture conditions
The E. coli strain harboring the λ-RED plasmid known as BW25113/pIJ790 and
the methylation deficient E. coli donor strain ET12567/pUZ8002 were provided by
the John Innes Institute (Norwich, UK) and have been described previously in
literature [19].
E. coli BW25113/pIJ790 was grown at 30οC in Lysogeny Broth (LB) media [63]
and super optimal broth (SOB) media [64], each containing 25 μg/ml of
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chloramphenicol while E. coli ET12567/pUZ8002 was grown at 37οC in LB media
containing 25 μg/ml kanamycin and 25 μg/ml chloramphenicol. Streptomyces
venezuelae was propagated on sporulation agar (SPA) plates [65] at 30οC while
SCM media was used for seed and large scale cultures.

2.3.3 DNA manipulation and construction of pMAR cosmid
The pSET1520 plasmid and 8A7 cosmid DNA were isolated from E. coli cells
using QIAprep Spin Miniprep kit (Qiagen, Valencia, CA). DNA sequencing was
performed at the MMI core facility and at The Primate Center, Oregon Health and
Sciences University (Portland, OR). Primer design and analysis of DNA
sequences was performed using MacVector (MacVector Inc., Cary, NC) and
Accelrys DS gene (Accelrys Inc., San Diego, CA) software.
In order to allow the integration of the 8A7 cosmid carrying the putative mar
cluster into the genome of Streptomyces, the 8A7 cosmid was first transformed
into E. coli BW25113/pIJ790 (recombination strain) via electroporation according
to standard protocol [19]. Then, the bla gene encoding resistance to ampicillin
antibiotic in the 8A7 cosmid was replaced with three genes using PCR targeted
recombination (Figure 11): oriT which is an origin of transfer, ΦC31 integrase
gene which allows for integration of the cosmid at the attB site in Streptomyces
genome, and aac(3)IV gene which allows for selection of exconjugants
expressing the mar cluster by conferring resistance to apramycin antibiotic
(Figure 11).
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Figure 11: Recombination strategy employed to generate an integrative mar gene cluster.
pSET 1520 plasmid was used as a template for PCR amplification of oriT, phiC31 integrase and
aac(3)IV. The PCR product was used to replace the bla gene in cosmid 8A7 via PCR targeted
recombination followed by site-specific integration of the modified 8A7 cosmid into S. venezuelae.
bla = β-lactamase; aac(3)IV = apramycin resistance gene; oriT = origin of transfer; attP/aatB =
phiC31 attachment site of phage/bacteria; int = phiC31 integrase.

The three genes aac(3)IV, oriT, and ΦC31int were amplified from pSET1520
plasmid template using 5’- TGA TAA ATG CTT CAA TAA TAT TGA AAA AGG
AAG AGT ATG GTG CAA TAC GAA TGG CGA AA -3’ as the forward primer and
5’- AAT CTA AAG TAT ATA TGA GTA AAC TTG GTC TGA CAG TTA CTA
CGC CGC TAC GTC TTC C -3’ as the reverse primer with the bases in bold italic
homologous to the bla gene of SuperCos1. Amplification of the three-gene 3966
bp long PCR product, was achieved using GeneAmp PCR system 2700 (Applied
Biosystems) according to the following protocol: initial denaturation at 98οC for 30
seconds followed by 30 cycles of amplification (denaturation at 98 οC for 10
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seconds, and annealing at 72οC for 1 minute) followed by a final extension step
for 10 minutes at 72οC. The PCR product was purified using QIAquick PCR
Purification kit (Qiagen, Valencia, CA) and the PCR was eluted using 10 μl of EB
buffer. A poly-A tail was added to the purified blunt-ended PCR product by
incubating it with Platinum PCR High Fidelity Supermix (Invitrogen) at 72 οC for 10
minutes. The PCR product was cloned into pCR8/GW/TOPO vector (Invitrogen)
to generate TOPO-pS1 that was transformed into Mach1 E. coli (Invitrogen).
After confirmation of the TOPO-pS1 plasmid DNA sequence, the plasmid was
digested with EcoRI and loaded onto a 1% agarose gel and subjected to gel
electrophoresis. The fragment corresponding to ~ 4 kbp three-gene was excised
from the gel and purified using QIAquick Gel Purification kit (Qiagen). The linear
purified aac(3)IV, oriT , and ΦC31int tri-gene was used in PCR targeted
recombination of 8A7 cosmid according to standard Red/ET recombination
protocol [19] to generate the pMAR cosmid which has the ability to integrate at
the attB site in the Streptomyces genome (Figure 11). The recombination of
pMAR cosmid was confirmed by PCR amplification of aac(3)IV, oriT, and
ΦC31int tri-gene using the same primers used above. The pMAR cosmid was
transformed into E. coli ET12537/pUZ8002 (donor strain) to generate ET/pMAR
donor strain which is apramycin resistant and ampicillin sensitive and capable of
conjugation with Streptomyces venezuelae (receiving strain).
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2.3.4 Conjugation of E.coli ET/pMAR and S. venezuelae
The conjugation between the E.coli ET/pMAR and S. venezuelae was done
according to standard protocol with minor modifications [65]. S. venezuelae was
propagated on SPA agar and incubated at 30 οC for 7 days. Fresh spores were
used to inoculate 25 ml of SGGP media [66] and was allowed to grow for 3 days
at 30οC. On day 3, 1 ml of the SGGP culture was used to inoculate 9 ml of TSB
media and was incubated at 30οC for 18 hours. At the same time, E. coli
ET/pMAR was streaked on LB-agar plates supplied with 50 μg/ml of apramycin
and 25 μg/ml of chloramphenicol and was incubated at 37οC for 18 hours. The
next day, 2 ml of the overnight S. venezuelae TSB culture was used to inoculate
18 ml of fresh TSB media and incubated at 30 οC for 18 hours while a single
colony from the E. coli ET/pMAR LB agar plate was used to inoculate 2 ml of
TSB media containing 50 μg/ml of apramycin and 25 μg/ml of chloramphenicol.
The next day, 1 ml of the overnight S. venezuelae TSB culture was used to
inoculate 9 ml of fresh TSB media and incubated at 30 οC for 3 hours while 100 μl
of the overnight E. coli ET/pMAR LB culture was used to inoculate 10 ml of TSB
media supplied with 50 μg/ml of apramycin and 25 μg/ml of chloramphenicol. E.
coli ET/pMAR was allowed to grow at 37οC until O.D600 ~ 0.4 was reached. Both
E. coli ET/pMAR and S. venezuelae cultures were centrifuged at 4οC and 5000
rpm for 5 minutes to recover the cells. The recovered cells were washed twice
with fresh TSB media to remove any inhibiting antibiotics and cells were collected
by centrifuge again. The cells of E. coli ET/pMAR (donor) and S. venezuelae
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(recipient) were finally suspended in 2 ml of TSB and mixed together in 1:1, 1:9
and 9:1 donor: receiver ratios and 100 μl of each mixture was spread onto predried AS1 media containing 10 mM MgCl2. After overnight incubation at 30οC,
each plate was overlaid with 1 ml of LB media containing 500 μg/ml nalidixic
acid, 500 μg/ml of apramycin and 500 μg/ml of kanamycin and plates were
returned to incubation at 30οC for an additional 7-14 days [65]. Colonies were
visible after approximately 3-5 days. The exconjugants expressing the mar
cluster were characterized by a distinctive red color and were propagated on
SPA plates supplied with 50 μg/ml apramycin. The new strain was named JND2.

2.3.5 LC/MS and MS/MS analysis of JND2 crude extract
To prepare extracts for MS analysis, fresh spores of S. venezuelae (wild type)
and S. venezuelae JND2 strain was used to inoculate 10 ml of SCM media. After
72 hrs, the cells were harvested and the cells’ organic constituents were
extracted with acetone. The organic content of the supernatant obtained after cell
harvest was extracted by a solid-phase extraction method using Amberlite XAD-7
resin where the supernatant was stirred with the resin for 2 hours followed by
filtration to collect the resin. The resin was washed with water and then the
organic content of the resin was obtained by washing with acetone. The acetone
extract was dried under vacuum and stored at -20οC till further analysis. The dry
extracts from wild type S. venezuelae and JND2 were dissolved in MS-grade
methanol and were injected directly into the mass spectrometer. Direct MS and
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Tandem MS experiments were conducted using a ThermoElectron LTQ-Orbitrap
high resolution mass spectrometer equipped with Accela HPLC system
(ThermoFinnigan) (Mass Spectrometry Facility, Portland State University). Data
was analyzed using Xcalibur software. For LC/MS analysis, the crude extract
from JND2 strain was dissolved in methanol and 20 μl of 0.5 mg/ml extract was
injected into MicroToF-Q mass spectrometer (Bruker, Billerica, MA) equipped
with an Agilent 1100 series HPLC (Agilent technologies, Santa Clara, CA) with
MWD detector (Mass Spectrometry Facility, Portland State University) using 2.1
x 250 mm, 5um, reverse phase Supelco

18

C-column (Supelco, St. Louis, MO)

and using a 50 min gradient from 5% ACN/H2O to 100 % ACN containing 0.05%
formic acid at flow rate of 200 μl/min.

2.3.6 Purification and characterization of marineosin from S. venezuelae JND2
Fresh spores of S. venezuelae JND2 were used to innoculate 10 ml of SCM
media containing 50 μg/ml of apramycin to generate a seed culture that was
incubated at 30οC, 220 rpm for 48 hours. 1% of the seed culture was used to
inoculate larger scale fermentations that were grown for an additional 7 days at
30οC, and 220 rpm.
The JND2 cells were harvested by centrifugation at 10000 rpm, 6 ο C for 10
minutes. The harvested cells were disrupted by the addition of acetone followed
by sonication for 5 minutes. After filtration using cotton wool, the acetone extract
was dried under vacuum and stored at -20οC till further analysis. The crude cell
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extract from JND2 strain was dissolved in methanol and purified using a Waters
HPLC equipped with a DWD detector using 20.0 x 250.0 mm, 10 μm, reverse
phase Ascentis
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C-column (Supelco, St. Louis, MO) using buffer A:

water/acetonitrile/methanol (5:1:4) and buffer B: 100% methanol using the
gradient specified in Table 2.

Time (min)
0
2.0
40.0
50.0
51.0
60.0

Flow
(ml/min)
10.0
10.0
10.0
10.0
10.0
10.0

%A

%B

90.0
90.0
0.0
0.0
90.0
90.0

10.0
10.0
100.0
100.0
10.0
10.0

Table 2: HPLC gradient for first purification of marineosin

The peak eluting at 45 minutes was collected, dried under vacuum and subjected
to another round of purification using an Agilent HPLC equipped with a MWD
detector using 4.6 x 150.0 mm, 3.5 μm, reverse phase Zorbax SB-18C-column
(Agilent technologies, Santa Clara, CA) using buffer A: water acidified with 0.05
% formic acid and buffer B: acetonitrile acidified with 0.05 % formic acid using the
gradient specified in Table 3. The peak with retention time of 12 minutes was
collected and dried under vacuum to yield pure marineosin.
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Time (min)
0.0
7.5
8.0
13.0
13.5
21.0
21.5
25.0
25.5
30.0

Flow
(ml/min)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0

%A

%B

75.0
75.0
50.0
50.0
25.0
25.0
0.0
0.0
75.0
75.0

25.0
25.0
50.0
50.0
75.0
75.0
100.0
100.0
25.0
25.0

Table 3: HPLC gradient used in second purification of marineosin

The dried marineosin was dissolved in acetone-d6 for characterization by 1HNMR.

1

H-NMR spectra was generated using a Bruker AMX-400 MHz

spectrometer (Bruker Daltonics), calibrated using TMS as an internal standard.

2.4 RESULTS AND DISCUSSION
2.4.1 Identification of the gene cluster responsible for the biosynthesis of
marineosin: The mar cluster
Heterologous expression of the putative mar gene cluster was pursued to verify
the role of the presumed cluster in the biosynthesis of marineosin. The 8A7
cosmid carrying the putative cluster was genetically engineered into the pMAR
cosmid which has the ability to integrate in the genome of S. venezuelae.
Conjugation was used to deliver pMAR cosmid into S. venezuelae to generate
the JND2 strain. Unlike the wild type S. venezuelae which is grey in color (Figure
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12), the JND2 strain is characterized by a distinctive red color. This change in
phenotype indicates that the expression of the gene cluster in question leads to
the accumulation of red-colored metabolites, although marineosin itself is not red
[53]. The red-colored metabolites could be undecylprodiginine (7) (Figure 4) or
other prodiginine analogs. S. venezuelae JND2 is also apramycin resistant unlike
the wild type, which is apramycin sensitive.

Figure 12: SPA agar plates showing change in phenotype of wild type S. venezuelae (left
panel, grey) as a result of expression of the mar gene cluster to yield S. venezuelae JND2
(right panel, red).

The MS profile of acetone extracts from wild type S. venezuelae shows the
expected [M+H]+ of m/z 470.31 and 526.34 corresponding to methymycin and
pikromycin antibiotics respectively, naturally produced by the strain [67] (Figure
13). However, the MS profile of S. venezuelae JND2 strain indicates the
presence of multiple new compounds in addition to methymycin and pikromycin
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that are absent from the wild type strain (Figure 13). Among the new compounds
detected in JND2 extract MS spectrum, is a compound with [M+H]+ of m/z 410.28
corresponding to molecular formula of C25H36O2N3 which matches the published
mass and molecular formula of marineosin [53].
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Figure 13: A comparison between the total ion spectrum of wild type S. venezuelae (top
panel) and S. venezuelae JND2 (bottom panel). The MS profile of the wild type S. venezuelae
+
(top panel) shows the presence of methymycin and pikromycin antibiotics with [M+H] of m/z
470.31 and 526.34 respectively, while the MS profile of S. venezuelae JND2 shows the putative
+
presence of marineosin with [M+H] of m/z 410.28 in addition to methymycin, pikromycin and
other new compounds.
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Comparing the MS/MS profile of the m/z 410.28 in the JND2 extract (Figure 14,
bottom panel) to that of a standard marineosin (Figure 14, top panel), reveals
that both compounds have exactly the same MS/MS profile where both
compounds have daughter fragments m/z 378.26 and 230.19 corresponding to
structures 20 and 21 (Figure 15), respectively.
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Figure 14: A comparison between the MS/MS profile of marineosin standard (top panel)
and the compound with m/z 410.28 in S. venezuelae JND2 extract (bottom panel).
Compounds in both top and bottom panels show the presence of m/z 230.19, m/z 302.21 and m/z
378.25.
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Figure 15: Fragment ions observed in the MS/MS profile of marineosin. Figure is adapted
from reference 53.

Moreover, LC/MS analysis (Figure 16) of the JND2 extract and a standard
marineosin sample shows that both marineosin standard (Figure 16, top panel)
and m/z 410.28 compound in the JND2 extract (Figure 16, bottom panel) have
almost the same retention time with only 0.2 minute difference.
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Figure 16: An LC/MS comparison between marineosin standard and JND2 extract. An
extracted ion chromatogram (EIC) of m/z 410.28 for marineosin standard (top panel) and JND2
extract (bottom panel).

The compound with [M+H]+ m/z 410.28 produced by S. venezuelae JND2, was
purified from the acetone extract via 2 rounds of HPLC purifications (Figure 17).
1

H-NMR spectral data (400 MHz, acetone-d6) of the purified compound (Figure

18) was found to be:
δ 10.99 (br, 1-NH), δ 8.26 (br, 1-NH), δ 6.98 (dd, J = 1.5 Hz and 2.5 Hz, 1H), δ
6.38 (dd, J = 1.5 Hz and 3.5 Hz, 1H), δ 6.1 (dd, J = 2.5 Hz and 3.5 Hz, 1H), δ
5.69 (t, J = 2.5 Hz, 1H), δ 5.45 (t, J = 3 Hz, 1H), δ 4.24 (m, J = 6.5 Hz, 1H), δ
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3.86 (t, J = 8.5 Hz, 1H), δ 3.41 (s, 3H), δ 2.91 (d, J = 12 Hz, 1H), δ 2.88 (dd, J =
8.5 Hz and 16 Hz, 2H), δ 2.32 (m, 1H), δ 2.23 (m, 2H), δ 1.88 (dd, J = 8.5 Hz and
16 Hz, 2H), δ 1.77 (m, J = 12 Hz, 2H), δ 1.61 (td, J = 6.5 Hz and 12 Hz, 2H), δ
1.51 (d, J = 7 Hz, 3H), δ 1.64 (m, 2H), δ 1.52 (m, 2H), δ 1.37 (m, 2H), δ 1.35 (m,
2H), δ 1.34 (m, 2H), δ 1.28 (m, 2H), δ 1.18 (m, 2H), δ 1.02 (m, 2H), δ 0.88 (m,
2H), δ 0.88 (m, 2H), δ 0.69 (m, 2H), δ 0.52 (m, 2H).

This data is consistent with the published data for marineosin [53] which proves
the identity of the [M+H]+ m/z 410.28 compound produced in S. venezuelae
JND2 as marineosin. Streptomyces venezuelae JND2 strain produces 2 mg/L of
marineosin vs. 0.4 mg/L from the original producer Streptomyces CNQ-617 [53].
Comparing the MS profile of JND2 cell extract to that of JND2 XAD-extract
reveals that marineosin is primarily located inside the cell and is not secreted into
the media.
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Figure 17: HPLC purrification of marineosin from S. venezuelae JND2. Marineosin was
purified from JND2 extract in 2 HPLC purification steps. The peak at 45 min from the first
purification (top panel) was collected and subjected into another round of HPLC purification
(bottom panel) to yield marineosin.
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1

Figure 18: H-NMR of marineosin isolated from S. venezuelae JND2.

The successful production of marineosin in the heterologous host, S. venezuelae
provides the first experimental evidence that marineosin is biosynthesized via a
red gene cluster homolog which raises interesting questions about the origin of
the spiroaminal ring oxygen of marineosin. To the best of our knowledge, the mar
cluster is also the first identified gene cluster to be involved in the biosynthesis of
a spiroaminal ring containing compound which will provide a wealth of
information on the biosynthesis of this unique and important class of natural
products. Having the mar cluster expressed in a heterologous host such as S.
venezuelae facilitates the engineering of marineosin analogs and allows for yield
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improvements of marineosin using methods such as over-expression of
regulatory genes in the mar gene cluster.

2.4.2 Hypotheses explaining the origin of the spiroaminal ring oxygen
As mentioned earlier in section 1.5.3, the mar gene cluster shows striking
homology and displays the same architecture of the red gene cluster responsible
for the biosynthesis of undecylprodiginine and streptorubin B in S. coelicolor
A(3)2, with the presence of only one extra dehydratase-encoding gene named,
marA (Figure 9). Interestingly, the results of all the studies presented in this
section indicate that the expression of the mar gene cluster in the heterologous
host, S. venezuelae, was successful and that the new strain, S. venezuelae
JND2, is fully capable of producing marineosin with three times higher yield than
the original producer. Therefore, the cloned mar gene cluster encodes most if not
all of the genes required to direct the biosynthesis of marineosin. We hypothesize
that the intramolecular cyclization and spiroaminal ring formation is catalyzed by
the dehydratase, MarA. However, the mar gene cluster lacks any dedicated
oxidases or p450 homologs that can explain the origin of the hydroxyl group in
the acyl chain of marineosin which is required for the biosynthesis of the
spiroaminl moiety (Figure 4) (10 and 11). There are four hypotheses (Figure 19)
that can explain the origin of that hydroxyl group:
1. The marG gene, which encodes the Rieske-oxygenase MarG, plays a dual
role in the biosynthesis of marineosin. In this case, MarG catalyzes the oxidative
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cyclization of the acyl chain of undecylprodiginine, like it normally does in the
biosynthesis of streptorubin B (Figure 5) [52] and also introduces the second
hydroxyl group required to initiate the biosynthesis of the spiroaminal moiety of
marineosin. If this hypothesis is correct, a deletion of marG gene from the mar
gene cluster should lead to the accumulation of undecylprodiginine as an
intermediate (Hypothesis no. 1, Figure 19).
2. An unidentified Mar enzyme catalyzes the required hydroxylation. The mar
gene cluster, as well as its red gene cluster homolog, encodes two genes of
unknown function named marT and marE and therefore were annotated as
hypothetical proteins. Deletion of one or both genes can be used to probe their
roles in the biosynthesis of marineosin (hypothesis no. 2, Figure 19).
3. Marineosin production in the original producer, Streptomyces CNQ-617
requires the presence of an extra tailoring oxidase enzyme which is not clustered
with the mar gene cluster. In this case, the biosynthesis of marineosin in S.
venezuelae can be explained by the presence of a promiscuous p450 oxidase
capable of hydroxylating the acyl chain of undecylprodiginine (7) to yield 2hydroxy-undecylprodiginine (25) and thus rescue marineosin production
(hypothesis no. 3, Figure 19). However, there is no evidence that S. venezuelae
harbors such an enzyme.
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Figure 19: Hypotheses explaining the biosynthetic origin of the spiroaminal oxygen of
marineosin. For details, please refer to text.

4. The hydroxyl group is incorporated early in the biosynthetic pathway due to the
incorporation of a 3-hydroxy-butyric acid starter unit (22) by the RedP homolog,
MarP, which is a 3-ketoacyl-ACP-synthase, to yield 2-hydroxy-dodecanoic acid
(23). 2-hydroxy-dodecanoic acid (23) becomes a substrate for the polyketide
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synthase, MarL to yield a 2-hydroxy-undecylpyrrole (2-hydroxy-UP) subunit (24).
MarH then catalyzes the condensation of the 2-hydroxy-UP subunit (24) with the
MBP subunit (14) (Figure 4), which leads to the biosynthesis of 2-hydroxyundecylprodiginine (25) rather than undecylprodiginine (7) (hypothesis no. 4,
Figure 19). In this case, all enzymes involved in the biosynthesis of 2-hydroxy-UP
subunit (24) as well as MarH and MarG must accept hydroxylated substrates
unlike their Red enzymes counterparts. If this hypothesis is correct, deletion of
marG gene from the mar gene cluster will lead to the accumulation of 2-hydroxyundecylprodiginine (25).

2.4.3 New compounds observed in S. venezuelae JND2
The prodiginine family of compounds is characterized by having a maximum UV
absorbance (λmax) of 530 nm due to aromatic ring system conjugation, and thus
has a distinctive red color. The λmax of marineosin standard is 320 nm due to
the reduction of one of the pyrrole rings (ring B, Figure 4) and loss of conjugation.
The extract of S. venezuelae JND2 was analyzed via MicroToF-Q mass
spectrometer using reverse phase HPLC equipped with MWD detector. The LCUV analysis of the extract indicates the presence of two groups of compounds: a
group of non-conjugated compounds with a λmax of 320 nm and a group of
conjugated red-colored compounds with a λmax of 530 nm. The non-conjugated
compounds include marineosin in addition to three other compounds named
JN422, JN424, and JN408 with [M+H]+ of m/z 422.26, 424.28, and 408.26 and
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molecular formulae C25H32O3N3, C25H34O3N3, and C25H34O2N3, respectively. The
conjugated, red-colored compounds include [M+H]+ m/z 406.25, 408.27, and
410.28 with respective molecular formulae of C25H32O2N3, C25H34O2N3, and
C25H36O2N3 in addition to a mixture of other red compounds (Figure 20).
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Figure 20: The LC-UV/MS profile S. venezuelae JND2. The blue chromatogram represents
absorption at 530 nm and the orange chromatogram represents absorption at 320 nm.

Based on our knowledge of prodiginines biosynthesis and the fact that
marineosin is non-conjugated, the accumulation of conjugated red-colored
compounds in S. venezuelae JND2 suggests that the reduction of the pyrrole ring
B of marineosin occurs later in the pathway. The detection of JN422 and JN424
compounds via LC/MS, which have extra oxygen in their molecular formulae, is
very intriguing as it suggests that these compounds have a second hydroxyl or
keto group in their structure. The fact that di-hydroxylated red compounds were
not detected suggests that the second hydroxylation occurs later in the pathway,
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due to the activity of either a Mar enzyme or a promiscuous p450 oxidase in S.
venezuelae. In the latter case, JN422 and JN424 would be artifacts of the
heterologous expression of the mar gene cluster and not true intermediates.
Undecylprodiginine (7) (Figure 4, Figure 19) production was not observed in this
strain which can be explained by two possibilities: either that undecylprodiginine
(7) is not an intermediate in the biosynthesis of marineosin altogether, consistent
with either hypothesis number 2 or 4 (Figure 19) or undecylprodiginine (7) is
produced but is converted to marineosin very quickly by the action of a Mar
enzyme or an additional p450 oxidase in S. venezuelae, which is consistent with
the other two hypotheses (Figure 19).

2.4.3 Comparison between the fragmentation patterns of undecylprodiginine,
marineosin, and JND2 compounds
The electrospray tandem mass spectrometry ES-MS/MS profile of the
prodiginines family of natural products is characterized by the neutral loss of m/z
15 which corresponds to the loss of a methyl radical from the pyrrole ring B to
generate odd electron fragments [68]. Upon ESI-CID fragmentation of
undecylprodiginine, protonation first occurs at the nitrogen atom of pyrrole ring B
which leads to electron delocalization and the subsequent formation of a pseudoseven-membered ring which is stabilized by conjugation. Therefore, the loss of a
methyl radical provides the most stable ground state [M+H]+ (Figure 21, top
panel). This fragmentation pattern was used to determine the structure of a
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prodiginine analog present in low concentration in Hahella chejuensis extract
without prior purification [68]. The same experiment was attempted using
undecylprodiginine and marineosin in order to understand the differences
between the two compounds when subjected to ESI-CID. This knowledge can
then be used to gain preliminary insight into the structure of other compounds
accumulated in S. venezuelae JND2 and other engineered strains, which will be
discussed in more detail in chapter 3.
In case of undecylprodiginine (Figure 21, top panel), a daughter fragment of m/z
379.26 corresponding to the neutral loss of m/z 15 (NL=15) was observed as
expected (Figure 21, top panel). However, in case of marineosin, a daughter
fragment of m/z 378.26 corresponding to the neutral loss of m/z 32 (NL=32)
rather than 15 was observed (Figure 21, bottom panel). In case of marineosin
(Figure 21, bottom panel), pyrrole ring B is not conjugated and therefore,
protonation of the nitrogen in ring B does not lead to charge delocalization and
subsequently, the pseudo-seven-membered ring, if formed, will not be stabilized
by conjugation as in the case of undecylprodiginine. Therefore, marineosin favors
the loss of a methanol molecule, NL=32 from ring B which probably creates the
most stable resonance-stabilized ground state [M+H]+ pyrrole ring and thus, the
generation of even electron fragments in ES-MS/MS (Figure 21).
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Figure 21: Mechanism and comparison between the MS/MS profile of undecylprodiginine
standard (top panel) and marineosin (bottom panel). A) The mechanism and MS/MS profile of
undecylprodiginine (top panel) show a daughter fragment of m/z 379.26 corresponding to the
neutral loss of m/z 15 (NL=15). The parent ion of undecylprodiginine, m/z 394.29 is not shown. B)
The mechanism and MS/MS profile of marineosin (bottom panel) show daughter fragments of m/z
378.26 corresponding to the neutral loss of m/z 32 (NL=32).
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2.5 CONCLUSION
A genomic library of Streptomyces CNQ-617 was generated by Reynolds KA and
co-workers and a red gene cluster homolog was identified and proposed to be
responsible for the biosynthesis of marineosin but that assumption was not
tested experimentally. The putative mar gene cluster has only one extra gene
named marA, encoding a dehydratase. We hypothesize that MarA is involved in
the biosynthesis of the spiroaminal ring of marineosin. The putative gene cluster
was expressed in the heterologous host S. venezuelae and the production of
marineosin was confirmed via tandem mass spectrometry, LC/MS and 1H-NMR
of marineosin purified from the engineered S. venezuelae JND2 strain. S.
venezuelae provides 3 times higher yield of marineosin than the original
producer, Streptomyces CNQ-617.
Four hypotheses were proposed to explain the origin of the hydroxyl group
required for the biosynthesis of the spiroaminal ring of marineosin. Deletion of
marG gene, encoding the Rieske oxygenase MarG, is necessary to provide
evidence supporting any of the proposed hypotheses and deletion of marA gene,
encoding the dehydratase MarA, is necessary to probe its role in the biosynthesis
of the spiroaminal ring.
A number of pathway intermediates and possibly some shunt metabolites were
observed in the acetone extract of S. venezuelae JND2. The intermediates were
either conjugated with bright red color or non-conjugated compounds.
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2.6 SIGNIFICANCE
We are reporting the first gene cluster experimentally proved responsible for the
biosynthesis of marineosin and the first gene cluster involved in the biosynthesis
of a spiroaminal natural product. The identification of the mar gene cluster and its
expression in a heterologous host will facilitate studying the biosynthesis of this
intriguing class of secondary metabolites by probing the role of individual genes
along the pathway. Engineering of gene deletion and/or replacement mutants
and analysis of the accumulating metabolites can provide analogs of marineosin.
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3. Probing the role of the oxidase, marG and the dehydratase, marA in the
biosynthesis of marineosin

3.1 SUMMARY
The role of MarG and MarA in the biosynthesis of marineosin was investigated
via gene replacement experiments, and the major metabolites accumulated in
the resultant mutant strains were purified and identified. The deletion of MarG, a
non-heme

iron

Rieske

oxygenase

led

to

the

accumulation

of

2-

hydroxyundecylprodiginine (26). This data disproves the hypothesis that MarG
catalyzes the introduction of the hydroxyl group required to initiate the
biosynthesis of the spiroaminal ring of marineosin, and suggests that the origin of
such –OH group is either a 3-hydroxybutyric acid starter unit recruited via MarP
or an unidentified hydroxylase potentially in the mar gene cluster. The deletion of
MarA, a putative dehydratase led to the accumulation of 2 marineosin analogs
named JN408 (31) and JN422 (32) with molecular formulae C25H33O2N3 and
C25H31O3N3, respectively. JN408 (31) is an oxidized marineosin, where ring B is
a pyrrole ring rather than dihydropyrrole, and JN422 (32) is a 9-keto derivative of
JN408. This suggested that MarA is not involved in the biosynthesis of the
spiroaminal ring of marineosin but is rather involved in the reduction of pyrrole
ring B. We propose that spiroaminal ring formation happens via a concerted nonenzymatic mechanism. Marineosin production was not observed in either marG
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or marA deletion mutants which suggest that MarG and MarA are crucial for the
biosynthesis of marineosin. From the above data, an experimentally-supported
scheme for the biosynthesis of marineosin was proposed.
3.2 INTRODUCTION
From our work detailed in Chapter 2, the gene cluster directing the biosynthesis
of marineosin; the mar gene cluster was expressed in the heterologous host S.
venezuelae and marineosin production was confirmed via mass spectrometry
and 1H-NMR of purified marineosin. The identified mar gene cluster has a high
degree of homology to the red gene cluster directing the biosynthesis of
undecylprodiginine (7) and streptorubin B (8) in S. coelicolor A(3)2. The current
knowledge of prodiginines biosynthesis does not explain the origin of the
spiroaminal ring or the enzymes involved in the reduction of pyrrole ring B of
marineosin. We proposed four hypotheses (Figure 19) to explain the biosynthesis
of marineosin in which MarG and MarA were proposed to have important roles in
the biosynthesis of marineosin. Additional experiments were needed to test these
hypotheses. In this study, we sought the deletion of marG and marA genes to
probe the role of their respective enzymes in the biosynthesis of marineosin as
well as propose a scheme for marineosin biosynthesis.
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3.3 MATERIALS AND METHODS
3.3.1 Antibiotics, enzymes and bacterial strains
All antibiotics, chemicals and HPLC-grade solvents were purchased from SigmaAldrich (St. Louis, MO) unless otherwise stated. HPLC-purified DNA-primers
were purchased from Integrated DNA technologies (Corvallis, IA). Phusion highfidelity polymerase was purchased from New England Biolabs (Ipswich, MA).
Information regarding bacterial strains used in recombination was detailed in
section 2.3.2.

3.3.2 Targeted gene disruption of marG and marA genes
The 1150 bp aadA gene and its promoter were amplified from pIJ788
spectinomycin resistance cassette [19], [20] using Phusion polymerase and
primers specified in Table 4 and according to the protocol in Table 5.
Primers for amplification of aadA gene
aadA_FWD
aadA_REV

5’- GTATACGGCTGACGCCGTTGGATA -3’
5’- GTATACTTATTTGCCGACTACCTTGGT -3’

Table 4: Primers used for PCR amplification of aadA gene from pIJ788. Bold, italicized and
underlined font represents restriction endonuclease site for Bstz17I.

30 X
98 οC

98 οC

64 οC

72 οC

72 οC

4 οC

30 sec

10 sec

15 sec

17 sec

10 min



Table 5: Protocol used in PCR amplification of aadA gene
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The PCR product was purified using QIAquick PCR Purification kit (Qiagen,
Valencia, CA) and was eluted using 10 μl of EB buffer. The PCR product was
directly used as a template for another PCR reaction using primers specified in
Table 6 and the protocol specified in Table 7.
Primers used for marG disruption
marG_KO_FWD

5’- GTGCTCGGCGGGAAACTCGAAAGAGAGAGGGACTG
CATGGTATACGGCTGACGCCGTTG -3’

marG_KO_REV

5’- GCCGTACCATGCGTCTTCGTCCGGGACGCCGCCGC
GTCAGTATACTTATTTGCCGACT -3’

Primers used for marA disruption
marA_KO_FWD

5’- TTGTACGCCCACGCTCCGGTGCACAGAATCGTGGCC
ATGGTATACGGCTGACGCCGTTG -3’

marA_KO_REV

5’- AGAGGCGACGGAGATCATGACGGGATACTTCTGGC
GTCAGTATACTTATTTGCCGACT -3’

Table 6: Primers used for disruption of marG and marA genes. Homology to the nucleotide
sequence flanking marG or marA is indicated by bold underlined font while the italicized font,
indicates homology to aadA gene.

30 X
98 οC

98 οC

64 οC

72 οC

72 οC

4 οC

30 sec

30 sec

19 sec

10 sec

10 min



Table 7: PCR protocol used in targeted disruption of marG and marA genes

The new generated PCR product was used, according to protocol, in the Red/ET
mediated targeted gene disruption [20] of either marG or marA genes in pMAR
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cosmid where the genes in question were replaced by aadA gene, a
spectinomycin resistance marker (Figure 22).
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Figure 22: Recombination strategy used to generate S. venezuelae JND2ΔG (top panel)
and S. venezuelae JND2ΔA (bottom panel). pIJ788 plasmid was used as a template for PCR
amplification of aadA gene, conferring resistance to spectinomycin antibiotic. The PCR product
was used to replace marG gene (top panel) and marA (bottom panel) in pMAR cosmid via PCR
targeted recombination. The mutated cosmids were transferred to S. venezuelae by either
protoplast transformation (marG, top panel) or by conjugation (marA, bottom panel) to generate
S. venezuelae JND2ΔG and S. venezuelae JND2ΔA respectively. aadA = adenyltransferase
gene.
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marG and marA gene replacements were confirmed by PCR using outer primers
that bind ~ 200 bp upstream and ~ 200 bp downstream of the amplified gene
(Table 8). The mutant cosmids were named pMARΔG and pMARΔA.

Outer primers used to verify gene deletion
marG_Out_FWD
marG_Out_REV
marA_Out_FWD

5’- ACACCGACGCGACATGGACC -3’
5’- CGGGCAGCTCCTCGTCCT -3’
5’- GTCGGCCGGTGACGGTGC -3’

marA_Out_REV

5’- GGAACGCGACGACAGCTAT -3’

Table 8: Primers used to verify marG and marA gene deletions

3.3.3 Generation of S. venezuelae JND2ΔG and S. venezuelae JND2ΔA
mutants
3.3.3.1 Generation of S. venezuelae JND2ΔG mutant
To generate S. venezuelae JND2ΔG mutant, the pMARΔG cosmid was
transformed into dam-/dcm- methylation deficient E. coli (New England Biolabs,
Ipswich, MA) and the dam-/dcm- cosmid was purified. Protoplasts of wild type S.
venzuelae were prepared according to the following protocol modified from
reference [69]:
S. venezuelae spores were propagated onto SPA agar and incubated at 30 οC
for 7 days. Fresh spores were used to inoculate 30 ml of SGGP media, in 300 ml
baffled flask, and the culture was allowed to grow overnight at 30 οC. Mycelia
were harvested by centrifugation at room temperature. The harvested mycelia
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were suspended in 8 ml P-buffer (sucrose, K2SO4, MgCl2.6H2O, and trace
elements) containing 1 mg/ml of lysozyme and then was incubated for 45 min at
30 οC. The mycelia suspension was mixed by pipetting up and down for 3 times
using a 5 ml pipette then returned for 30 οC incubation for an additional 15 min. 5
ml of fresh P-buffer were added followed by pipetting up and down for 3 times
using a 5 ml pipette followed by filtration through sterile cotton wool. The filtrate
was centrifuged for 7 min at room temperature at 3000 rpm and the precipitated
protoplasts were washed twice with fresh P-buffer. The protoplasts were finally
suspended in 5 ml P-buffer and aliquoted as 250 μl volumes. For transformation
of dam-/dcm- pMARΔG cosmid, the following protocol, modified from reference
[69], was used:
1 ml of sterile PEG 8000 was melted in microwave for 20 sec and then mixed
with 3 ml of fresh P-buffer to form a 25% PEG 8000 solution. Quick-thawed
protoplasts were centrifuged at room temperature for 2 min at 3000 rpm,
decanted and the precipitated cells were suspended in the 100 μl left. 1 μg of
dam-/dcm- pMARΔG cosmid were added to the protoplasts immediately followed
by the addition of 600 μl of 25% PEG 8000 solution. 50 μl transformation mixture
was spread onto pre-dried R2YE plates and incubated overnight at room
temperature. Plates were overlaid with 1 ml LB broth containing 500 μg/ml
spectinomycin and 500 μg/ml of apramycin and plates were incubated at 30 οC
for 5-7 days. Transformants were red in color and was propagated onto SPA
agar plates supplied with 50 μg/ml spectinomycin and 50 μg/ml apramycin.
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3.3.3.2 Generation of S. venezuelae JND2ΔA mutant
To generate S. venezuelae JND2ΔA mutant, pMARΔA cosmid was transformed
into E. coli ET12537/pUZ8002 (donor strain) which was later used in conjugation
with wild type S. venezuelae as specified in section 2.3.4 with the addition of 50
μg/ml of spectinomycin and 50 μg/ml of apramycin.

3.3.4 LC/MS and MS/MS analysis of S. venezuelae JND2ΔG and S.
venezuelae JND2ΔA
S. venezuelae JND2ΔG and S. venezuelae JND2ΔA strains were propagated on
SPA agar containing 50 μg/ml of apramycin and spectinomycin antibiotics. Fresh
spores were used to inoculate 10 ml of SCM media containing the same
antibiotics. The mycelia were harvested after 72 hours by centrifugation at 5000
rpm, 4 οC, for 10 minutes. The cells were lysed by the addition of acetone
followed by sonication. The acetone extract was concentrated under vacuum and
the dried acetone extract was dissolved in methanol prior to MS analysis. The
acetone extract of S. venezuelae JND2ΔG was analyzed using ThermoElectron
LTQ-Orbitrap mass spectrometer equipped with an Agilent MWD HPLC using
buffer A: water/acetonitrile/methanol (5:1:4) and buffer B: 100 % methanol
according to protocol specified in Table 9. The acetone extract of S. venezuelae
JND2ΔA was analyzed using MicroToF-Q mass spectrometer equipped with an
Agilent 1100 series HPLC using buffer A: water with 0.1 % formic acid and buffer
B: acetonitrile wilth 0.1% formic acid and according to protocol specified in Table
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10. The LC/MS analysis of both strains was done using 2.1 x 250 mm, 5 μm,
reverse phase Supelco 18C-column (Supelco, St. Louis, MO).

Time (min)
0
5.0
40.0
50.0
51.0
60.0

Flow
(ml/min)
0.2
0.2
0.2
0.2
0.2
0.2

%A

%B

90.0
90.0
0.0
0.0
90.0
90.0

10.0
10.0
100.0
100.0
10.0
10.0

Table 9: HPLC conditions used in the LC/MS analysis of S. venezuelae JND2ΔG

Time (min)
0
2.0
25.0
30.0
31.0
36.0

Flow
(ml/min)
0.2
0.2
0.2
0.2
0.2
0.2

%A

%B

95.0
95.0
0.0
0.0
95.0
95.0

5.0
5.0
100.0
100.0
5.0
5.0

Table 10: HPLC conditions used in the LC/MS analysis of S. venezuelae JND2ΔA
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3.3.5 Purification and structure elucidation of compounds isolated from S.
venezuelae JND2ΔG and S. venezuelae JND2ΔA
3.3.5.1 Purification and structure elucidation of G410 from S.
venezuelae JND2ΔG
Spores of S. venezuelae JND2ΔG were propagated onto SPA agar plates
supplied with 50 μg/ml of apramycin and 50 μg/ml of spectinomycin antibiotics.
The plates were incubated at 30 οC for 7 days and fresh spores were used to
inoculate 10 ml of SCM media, in 50 ml flasks, supplied with 50 μg/ml of
apramycin and 50 μg/ml of spectinomycin antibiotics to form a seed culture.
Once the seed culture started to produce a red color, approximately 48-72 hours
after incubation, it was used to inoculate large scale fermentations of SCM
media, 1L each in a 4L baffled flasks, at 1% v/v. Large fermentations were also
supplied with the same antibiotics, at the same concentrations, and were
incubated at 30 οC for 6 days and 220 rpms. The mycelia were harvested by
centrifugation at 10000 rpm, 6 οC for 10 min. The harvested cells were disrupted
by the addition of acetone followed by sonication 2 times, 5 min each. The
acetone extract was dried under vacuum and the residual water was partitioned
3x with ethyl acetate. The ethyl acetate fraction was evaporated under vacuum
and the dried extract was stored at -20 οC until further use.
The crude extract was dissolved in methanol to yield 10 mg/ml solution and was
purified using a Waters HPLC equipped with a DWD detector using 20.0 x 250.0
mm, 10 μm, reverse phase Ascentis

18

C-column (Supelco, St. Louis, MO) using
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buffer A: water/acetonitrile/methanol (5:1:4) and buffer B: 100% methanol using
the gradient specified in Table 11.

Time (min)
0
2.0
40.0
50.0
51.0
60.0

Flow
(ml/min)
10.0
10.0
10.0
10.0
10.0
10.0

%A

%B

90.0
90.0
0.0
0.0
90.0
90.0

10.0
10.0
100.0
100.0
10.0
10.0

Table 11: HPLC conditions for first round of G410 purification

The peak eluting at retention time 25 min (Figure 23) was collected, dried under
vaccum and the residual water was removed by lyophilization. The 25 min
fraction was dissolved in choloroform and loaded onto 20 x 20 cm preparative
silica gel 60A TLC plates (Whatman). The TLC plate was developed using 50 %
ethyl acetate/hexane mixture. The bottom layer was excised from the TLC plate
and extracted with acetone (Figure 24).
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Figure 23: First HPLC purification of G410. Peak at retention time 25 minutes was collected,
concentrated and subjected to preparative TLC.

Figure 24: Preparative TLC purification of G410. The arrow show the layer that was later
excised from the TLC plate and subjected to another round of HPLC purification.
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The semi-pure G410 was subjected to a final round of HPLC purification using an
Agilent HPLC equipped with a MWD detector using 10.0 x 250.0 mm, 5 μm, and
reverse phase 18C-phenomenex column using method specified in Table 12.

Time (min)
0
25.0
30.0
31.0
40.0

Flow
(ml/min)
4.0
4.0
4.0
4.0
4.0

%A

%B

95.0
0.0
0.0
95.0
95.0

5.0
100.0
100.0
5.0
5.0

Table 12: HPLC method for final purification of G410

Peak eluting at retention time 14 min was collected, dried under vacuum and the
residual water was eliminated via lyophilization to yield 1 mg of pure G410.
DAD1 B, Sig=320,4 Ref=off, TT (SHAIMAA\04-26-12-G410-1.D)
DAD1 C, Sig=530,4 Ref=off, TT (SHAIMAA\04-26-12-G410-1.D)
DAD1 A, Sig=254,16 Ref=off, TT (SHAIMAA\04-26-12-G410-1.D)
mAU
2500

2000

1500

1000

500

0

0

5

10

15

20

25

30

35

min

Figure 25: Final HPLC purification of G410. The peak eluting at 14 min was collected and
evaporated to yield pure G410.
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The 98 % pure G410 was dissolved in acetone-d6 for NMR characterization.
NMR spectra were obtained using a Bruker AMX - 600 MHz spectrometer
(Bruker Daltonics) calibrated using residual acetone peak at 2.05 ppm.

3.3.5.2 Purification and structure elucidation of JN422 and JN408 from
S. venezuelae JND2ΔA
Spores of S. venezuelae JND2ΔA were propagated onto SPA agar plates
supplied with 50 μg/ml of apramycin and 50 μg/ml of spectinomycin antibiotics.
For large scale purification, plates were incubated at 30 οC for 7 days and fresh
spores were directly used to inoculate 60-100 ml of SCM media, in 300-500 ml
flasks, supplied with 50 μg/ml of apramycin and 50 μg/ml of spectinomycin
antibiotics. Large scale production from seed culture or using bigger flasks was
unsuccessful for this strain. Flasks were incubated at 30 οC for 6 days and 220
rpm. The mycelia were harvested by centrifugation at 10000 rpm, 6 οC for 10
min. The harvested cells were disrupted by the addition of acetone followed by
sonication 2 times, 5 min each. The acetone extract was dried under vacuum and
the residual water was removed by lyophilization. The crude acetone extract was
stored at -20 οC until further use. At time of purification, the extract was dissolved
in methanol and the extract was partially purified using Agilent HPLC equipped
with a MWD detector using 10.0 x 250.0 mm, 5 μm, and reverse phase
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C-

phenomenex column using the method specified in Table 13.
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Flow
(ml/min)
4.0
4.0
4.0
4.0
4.0

Time (min)
0
30.0
35.0
36.0
46.0

%A

%B

95.0
15.0
15.0
95.0
95.0

5.0
85.0
85.0
5.0
5.0

Table 13: HPLC method used in the purification of JN422 and JN408 from S. venezuelae
JND2ΔA.

The peaks with retention time 15 min and 21 min (Figure 26); corresponding to
JN422 and JN408 respectively, were collected and concentrated under vacuum.
The residual water was removed via lyophilization and the semi-pure compounds
were each subjected to another round of HPLC purification using the same
conditions as specified in Table 13 (Figure 27).

D A D 1 A , S ig = 2 5 4 ,1 6 R e f= o ff, T T (S H A IM A A \0 5 -2 4 -1 2 -A -K N O C K -5 .D )
D A D 1 B , S ig = 3 2 0 ,4 R e f= o ff, T T (S H A IM A A \0 5 -2 4 -1 2 -A -K N O C K -5 .D )
D A D 1 C , S ig = 5 3 0 ,4 R e f= o ff, T T (S H A IM A A \0 5 -2 4 -1 2 -A -K N O C K -5 .D )
mAU

2500

2000

1500

1000

500

0

0

5

10

15

20

25

30

35

40

4 5 m in

Figure 26: First HPLC purification of JN422 and JN408 from S. venezuelae JND2ΔA. The
peak with retention time of 15 minutes corresponds to JN422 while, the peak with retention time
of 21 minutes corresponds to JN408. Both peaks were collected and subjected to another round
of HPLC purification.
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D A D 1 A , S ig = 2 5 4 ,1 6 R e f= o ff, T T (S H A IM A A \0 6 -1 2 -1 2 -JN 4 2 2 P U R IF IC A T IO N -1 .D )
D A D 1 B , S ig = 3 2 0 ,4 R e f= o ff, T T (S H A IM A A \0 6 -1 2 -1 2 -JN 4 2 2 P U R IF IC A T IO N -1 .D )
D A D 1 C , S ig = 5 3 0 ,4 R e f= o ff, T T (S H A IM A A \0 6 -1 2 -1 2 -JN 4 2 2 P U R IF IC A T IO N -1 .D )
mAU
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D A D 1 A , S ig = 2 5 4 ,1 6 R e f= o ff, T T (S H A IM A A \0 6 -0 8 -1 2 -JN 4 0 8 P U R IF IC A T IO N -1 .D )
D A D 1 B , S ig = 3 2 0 ,4 R e f= o ff, T T (S H A IM A A \0 6 -0 8 -1 2 -JN 4 0 8 P U R IF IC A T IO N -1 .D )
D A D 1 C , S ig = 5 3 0 ,4 R e f= o ff, T T (S H A IM A A \0 6 -0 8 -1 2 -JN 4 0 8 P U R IF IC A T IO N -1 .D )
mAU
1000

800

600

400

200

0

0

5

10

15

Figure 27: Second HPLC purification of JN422 (top panel) and JN408 (bottom panel). The
peak with retention time of 15 minutes (top panel) corresponds to JN422. The peak with retention
time of 22 minutes (bottom panel) corresponds to JN408.
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The peak with retention time 15 min (top chromatogram, Figure 27) was collected
and dried under vacuum. Residual water was removed via lyophilization to yield
1 mg of 90 % pure JN422 (Figure 28) while collection of peak with retention time
of 21 min (bottom chromatogram, Figure 27) and lyophilization yielded 0.5 mg of
95 % pure JN408 (Figure 29). Purity estimations were based on HPLC, MS and
NMR data.

DAD1 B, Sig=320,4 Ref=off (SHAIMAA\JN422-PURE.D)
DAD1 C, Sig=530,4 Ref=off (SHAIMAA\JN422-PURE.D)
mAU
700
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500

400

300

200

100

0

-100
0
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10

15

20

25

30

min

Figure 28: HPLC chromatogram of pure JN422
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D A D 1 B , S ig = 3 2 0 ,4 R e f= o ff (S H A IM A A \J N 4 0 8 -P U R E -2 .D )
D A D 1 C , S ig = 5 3 0 ,4 R e f= o ff (S H A IM A A \J N 4 0 8 -P U R E -2 .D )
mAU
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Figure 29: HPLC chromatogram of pure JN408

Pure dried JN422 and JN408 were each dissolved in acetone-d6 for NMR
characterization. NMR spectra were obtained using a Bruker AMX - 600 MHz
spectrometer (Bruker Daltonics) calibrated using residual acetone peak at 2.05
ppm.
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3.4 RESULTS AND DISCUSSION
3.4.1 The role of MarG and MarA in the biosynthesis of marineosin
3.4.1.1 The role of MarG in the biosynthesis of marineosin
3.4.1.1.1 Sequence analysis of marG
The marG gene is 1356 bp long with a predicted protein sequence consists of
450 amino acids, corresponding to a calculated molecular weight of 50.96 kDa.
MarG shares a relatively lower degree of annotated identity (65% identity) to its
red gene cluster counterpart, RedG when compared to homologies among other
red and mar homologs (Table 1). Both enzymes belong to the family of nonheme iron Rieske oxygenases.
Typically, non-heme iron Rieske-oxygenases are multi-component enzyme
systems consisting of a reductase and an oxygenase component. The
oxygenase component of the Rieske-oxygenases is characterized by the
presence of highly conserved CXH, CXXH and DXHX4H motifs. The histidine
amino acid residues in the CXH and CXXH motifs are required to coordinate one
iron of the [2Fe-2S] cluster while the cysteine amino acid residues are
responsible for the coordination of the second iron atom [70] , [71]. It should be
noted that the histidine-liganded iron is the one undergoing reduction from Fe 3+
to Fe2+ after the gain of an electron [72–75]. The histidine amino acid residue in
the DXHX4H motif is required to coordinate a mononuclear non-heme iron center,
which performs the catalysis.

The Rieske center transfers electrons from

reductive component to the mononuclear iron center via the aspartate amino acid
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residue in the DXHX4H motif [52]. The mononuclear iron forms a 2-His-1carboxylate facial triad that allows the iron center to bind three exogenous
ligands, one of which is molecular oxygen [76]. The activated metal-oxygen
intermediate can catalyze numerous kinds of reactions such as mono- and dihydroxylations of aromatic rings and oxidative ring cyclizations [77]. It has been
proposed from numerous structural analyses of this class of enzymes, that the
identity of the ligand trans to the oxygen dictates the type of reaction this class of
enzymes catalyze. While both MarG and RedG have conserved CXH and CXXH
motifs at their N-terminal end, both enzymes have EXHX4H motif at their Cterminal end rather than DXHX4H motif characteristic to other Rieskeoxygenases (Figure 30). Comparison of MarG and RedG with RphG and McpG,
another two Rieske oxygenases proposed to be involved in the biosynthesis of
roseophilin (26) and metacycloprodiginine (9) (Figure 31), both cyclic prodiginine
analogs, indicates that all four enzymes have the same aspartate to glutamate
modification. Although both amino acids have acidic nature and should catalyze
the same types of reactions, an aspartate to glutamate mutation of naphthalene
dioxygenase Rieske enzyme yielded an inactive enzyme [78]. Based on that
study, we are proposing that the EXHX4H motif at the C-terminal end of MarG
and other Rieske oxygenases involved in carbon-carbon ring closures may be
crucial for catalysis.
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Figure 30: Sequence alignment of MarG and RedG with other Rieske-oxygenases. MarG
and RedG share the CXH, CXXH motifs of other Rieske-oxygenases at their N-terminal end and
DXXHX4H motif at the C-terminal end. It should be noted that the conserved aspartate (D) is
glutamate (E) in MarG and RedG.

Figure 31: Structure of roseophilin and metacycloprodiginine: two cyclic prodiginine
analogs.
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3.4.1.1.2 Targeted gene replacement of marG and the generation of S.
venezuelae JND2ΔG: A marG knockout strain
In Section 2.4.2, we proposed that undecylprodiginine (7) is a possible
intermediate along the pathway that leads to the biosynthesis of marineosin. We
also hypothesized that MarG enzyme, a Rieske oxygenase, could be involved in
the introduction a hydroxyl group to the acyl chain of undecylprodiginine (7)
intermediate. This hydroxylation is essential for the biosynthesis of the
spiroaminal moiety of marineosin in hypothesis No. 1 (Figure 19). To test this
hypothesis, marG gene encoding the Rieske-oxygenase MarG in the pMAR
cosmid, was replaced with a spectinomycin resistance marker gene called aadA.
The gene replacement was confirmed via PCR using primers designed to amplify
the region flanking the marG gene. The PCR of pMAR cosmid using these
primers led to the amplification of a fragment of ~ 1800 bp corresponding to
marG gene (1356 bp) plus the flanking 400 bp (lane C, Figure 32). When the
PCR done using the same primers using marG replacement mutant cosmid,
pMARΔG led to the amplification of ~ 1500 bp fragment corresponding to aadA
gene (1150 bp) plus the flanking 400 bp (lane ΔG, Figure 32).
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Figure 32: Confirmation of marG replacement, from pMAR cosmid, with aadA gene
conferring resistance to spectinomycin antibiotic. Lane L = DNA ladder, lane C = PCR
control performed using pMAR cosmid, lane ΔG = PCR performed using pMARΔG cosmid.

The mutant cosmid, pMARΔG was delivered to wild type S. venezuelae via
protoplast transformation and the new strain was named S. venezuelae
JND2ΔG. The new mutant strain is apramycin and spectinomycin resistant and is
bright red in color.

3.4.1.1.3 MS, LC/MS and LC-UV/MS analysis of S. venezuelae JND2ΔG
In order to determine the main metabolites accumulated as a result of marG
replacement, the MS profile of the crude acetone extract of S. venezuelae
JND2ΔG was determined using ThermoElectron LTQ-Orbitrap high resolution
mass analyzer. The analysis was run side by side with crude acetone extracts of
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both, wild type S. venezuelae and S. venezuelae JND2, marineosin producer
strain (Figure 33).
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Figure 33: Comparison of the MS profiles of S. venezuelae JND2ΔG (top panel), JND2
strain (middle) and wild type S. venezuelae (bottom). JND2ΔG (top panel) and JND2 (middle
panel) strains have the same MS profile where both strains show a compound of m/z 410.28 in
addition to the metabolites normally produced by the wild type S. venezuelae (bottom) such as
methymycin and pikromycin, m/z 470.31 and 526.34 respectively.

The MS profile of both JND2ΔG and JND2 strains was found to be different from
that of wild type S. venezuelae. In addition to methymycin and pikromycin
antibiotics, both strains share the accumulation of a compound of [M+H] m/z
410.28 and corresponding molecular formula C25H36O2N3, which is the same as
that reported for marineosin [53]. Since production of marineosin by JND2 strain
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was already demonstrated in section 2.4.1, this preliminary data suggested that
JND2ΔG mutant strain also produces marineosin and therefore, MarG is not
required for the biosynthesis of marineosin. However, analysis of the same
acetone extract using LC/MS indicated that both marineosin in JND2 strain and
m/z 410.28 compound in JND2ΔG mutant strain have different retention times
(Figure 34) and that the compounds are different.

RT: 0.00 - 60.01
NL: 3.08E8
m/z= 410.27-410.29
F: FTMS + p ESI Full
ms [250.00-1000.00]
MS
G-knockout-spores2

31.20

100
90

31.48

Relative Abundance

80
70
60
50
40
30
20
10
0
100

NL: 4.59E8
m/z= 410.27-410.29
F: FTMS + p ESI Full
ms [250.00-1000.00]
MS JND2

37.80
37.90

90
80
70
60
50
40
30
20
10
0
0

5

10

15

20

25

30
Time (min)

35

40

45

50

55

60

Figure 34: EIC of m/z 410.28 in S. venezuelae JND2ΔG (top panel) and S. venezuelae JND2
(bottom panel). The extracted ion chromatogram (EIC) of m/z 410.28 from the LC/MS of both
marG replacement mutant (top panel) and JND2 strains (bottom).
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As described in section 2.4.3, LC/UV analysis of the crude acetone extract of S.
venezuelae JND2 indicates the presence of two groups of compounds: a group
with a UV λmax of 320 nm and a group of λmax of 530 nm. The LC-UV/MS
chromatogram of S. venezuelae JND2ΔG on the other hand, has only one group
of red-colored compounds characterized with λmax 530 nm which indicates that
deletion of marG abolishes the production of marineosin and other nonconjugated compounds observed in JND2 strain (Figure 35). These results
demonstrate that marG is essential for the biosynthesis of marineosin and
supports the hypothesis that the loss of conjugation and hence; the red color,
occurs at a later step of the biosynthetic pathway.
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Figure 35: The LC-UV/MS profile of S. venezuelae JND2ΔG. The red chromatogram
represents absorption at 530 nm while blue chromatogram represents absorption at 320 nm.
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Undecylprodiginine (7) production was not observed in this strain which indicates
that MarG is not responsible for the introduction of the hydroxyl group required to
initiate the biosynthesis of the spiroaminal ring of marineosin. This observation
excludes hypothesis no. 1 proposed in section 2.4.2 (Figure 19). It should be
noted that some of the non-conjugated compounds were di-hydroxylated, which
may indicate that MarG is responsible for the introduction of that additional
hydroxyl group.
3.4.1.1.4

2-hydroxy-undecylprodiginine

is

the

main

metabolite

accumulating in S. venezuelae JND2ΔG
The main compound produced by S. venezuelae JND2ΔG; a marG mutant, was
named G410 (27) (Figure 36). The compound was isolated from the crude
acetone extract of S. venezuelae JND2ΔG using ethyl acetate extraction, HPLC,
preparative TLC and a final HPLC purification step to yield ~ 0.5 mg of 95% pure
compound (Figure 37). Detailed analysis of the MS, UV, IR and NMR spectral
data of G410 compound indicated its identity to be 2-hydroxyundecylprodiginine
(27) (Figure 36).

Figure 36: Structure of 2-hydroxyundecylprodiginine, G410
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Figure 37: HPLC chromatogram of 95% pure G410. The red chromatogram represents
absorption at 530 nm while blue chromatogram represents absorption at 320 nm.

The UV spectrum of G410 (27) (Figure 38) has a prominent λmax of 530 nm,
characteristic to prodiginines family of natural products due to their distinct red
color. This observation suggested a fully conjugated tripyrrole skeleton for G410
(27) similar to that of undecylprodiginine (7).
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Figure 38: UV spectrum of G410

HR-ESI-MS analysis of G410 (27) exhibits [M+H]+ of m/z 410.2807 (Figure 39).
The acquired mass was analyzed for molecular formula C25H36O2N3 or,
C25H35O2N3 without the H-adduct. The difference between the mass acquired for
G410 and the mass of the predicted molecular formula is only m/z 0.0005 (Figure
40). The theoretical isotope pattern of the predicted molecular formula was found
to be identical to the isotope pattern acquired for G410 (27) (Figure 40). This
molecular formula indicates an index of hydrogen deficiency equivalent to ten or
the presence of ten degrees of unsaturation.
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Figure 39: HR-ESI-MS of G410
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Figure 40: Comparison between the acquired (top panel) mass and isotope pattern of G410
and predicted mass and isotope pattern for molecular formula, C25H36O2N3 (bottom panel).
There is a difference of only m/z 0.0005 between the acquired and the predicted formula.
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The MS/MS fragmentation profile of G410 (27) has daughter fragments of m/z
395.33, 392.33, and 378.33 equivalent to the loss of m/z 18, 15 and 32
respectively (Figure 41). This fragmentation is consistent with the loss of water, a
methyl radical and/or methanol, respectively (Figure 42). As described in section
2.4.3, The loss of a methyl radical or m/z 15 is characteristic to prodiginines
family of natural products such as undecylprodiginine (7) but was not observed
for marineosin (Figure 21) [68].
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Figure 41: The MS/MS profile of G410. Daughter fragments of m/z 395.33, 392.33, and 378.33
equivalent to the loss of m/z 18, 15 and 32 respectively. The parent ion, m/z 410.28 is not shown.

Figure 42: Fragment ions observed in the MS/MS profile of G410
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The IR spectrum of G410 (27) (Figure 43) provided additional evidence
supporting the presence of a hydroxyl group as the spectrum has a broad peak
at max 3354 cm-1 and 1710 cm-1 which is characteristic for O-H stretch and C-O
stretch, respectively. Other peaks were observed at max 2921, 2852, 1630, 1605,
1550, 1464, 1367, 1264, 1185, 1041, 959, and 797 cm-1.

1.0

2921

0.6

1041
959

2852

0.7

0.5
4000

3000

797

0.8

1710
1 6 0 51 6 3 0
1550
1464
1367
1264
1185

3354

Percen t T ran s mittan ce

0.9

2000

1000

Wavenumbers

Figure 43: IR spectrum of G410

All of these spectral analyses suggested that G410 is an undecylprodiginine
analog with a –OH substituent, and therefore, further NMR spectral analyses
were done side by side with undecylprodiginine standard (7) (Table 14), to
facilitate structure comparison. The 1H-NMR spectrum (Figure 44) of G410 (27)
has 7 peaks with chemical shifts δ 6 -7 ppm which indicates the presence of 7
aromatic protons at δ 6.02 (d, J = 5.16 Hz), δ 6.15 (s), δ 6.24(t, J = 4.87 and 8.89
90

Hz), δ 6.58 (d, J = 5.2 Hz), δ 6.74 (s), δ 6.78 (d, J = 5.78 Hz), and δ 7.02 (br).
This is similar to the 7 aromatic protons present in 1H-NMR (Figure 45) of
undecylprodiginine (7). 1H-1H 2D TOCSY correlations among these aromatic
protons (Figure 46), and comparing it to the 1H-1H 2D TOCSY correlations of
undecylprodiginine (Figure 47), illustrated that the 7 aromatic protons were
components of three pyrrole rings.
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1

Figure 44: H-NMR spectrum of G410. Structure shown above.
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1

Figure 45: H-NMR spectrum of the HCl salt of undecylprodiginine standard. Structure
shown above.
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Figure 46: H- H 2D TOCSY correlations among aromatic protons of G410 and UP
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Figure 47: H- H 2D TOCSY NMR spectrum of G410 (top panel) and UP (bottom panel) aromatic region expanded.
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Comparison of the 1H-NMR of the aliphatic region of both compounds, revealed
that G410 (27) has an extra proton with chemical shift δ 3.67 ppm (m), consistent
with a –CH-OH (Figure 44). The characteristic methyl protons at C-24 in G410
(26) are slightly shifted downfield (δ 1.09) relative to the same protons in UP (7)
(δ 0.86) (Figure 48) suggesting their proximity to a heteroatom. Also, the protons
at C-24 in G410 show a prominent doublet splitting (J = 9.18 Hz) while the same
protons in UP, show a triplet splitting (J = 7.17 Hz). This splitting pattern
suggested that the methyl group at position 24 of G410 is adjacent to a –CH
group rather than a –CH2 group (Figure 48) which is consistent with the presence
of –CH-OH at C-23 of G410 (27).
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1

Figure 48: H-NMR spectrum showing comparison between the splitting pattern of methyl
protons at C-24 in undecylprodiginine (red, top) and G410 (blue, bottom)
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1

H-1H 2D COSY (Figure 49) and 1H-1H 2D TOCSY NMR (Figure 50) correlations

between protons at C-24 and C-23 in G410, confirmed the position of –CH-OH
group to be adjacent to the terminal methyl at C-24 (Figure 49), (Figure 50). Such
correlations are absent from the

1

H-1H 2D TOCSY NMR spectrum of

undecylprodiginine (7) (Figure 51).
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Figure 49: H- H 2D COSY NMR correlations between C-22, C-23, and C-24 of G410.
Structure shown above.
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Figure 50: H- H 2D TOCSY correlations among C-22, C-23 and C-24 of G410. Structure is
shown above.
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Figure 51: H- H 2D TOCSY correlations of the aliphatic region of undecylprodiginine
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All the above experiments as well as a detailed comparison between the
chemical shifts of both undecylprodiginine (7) and G410 (27) (Table 14),
confirmed the identity of G410 as 2-hydroxyundecylprodiginine. It should be
noted that the chemical shifts reported for undecylprodiginine (7) protons are
slightly shifted downfield as the compound is in the HCl salt form. The full 1H-1H
2D TOCSY spectra of G410 (27) and undecylprodiginine (7) is provided in Figure
52 and Figure 53, respectively.
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Table 14: NMR Spectral data for G410 (600 MHz, Acetone-d6) and side by side comparison
of G410 and UP

G410
δH*
7.02

UP
δH**
7.38

6.24
6.78

6.41
7.24

6.74

7.15

8
9

6.15

6.65

10
11
12

6.58
6.02

7.07
6.31

13
14
15

2.70
1.69

2.92
1.79

16
17
18

1.33
1.33
1.33

1.38
1.38
1.38

19
20

1.33
1.33

1.38
1.38

21
22
23

1.33
1.34
3.67

1.38
1.38
1.28

24
25

1.09
3.91

0.86
4.09

Position*
1
2
3
4
5
6
7

1

*Assignments are for protons bonded to the specified positions using 1D ( H), and 2D (COSY,
TOCSY) NMR spectroscopy in comparison to UP. ** The chemical shifts reported are for the HCl
salt of UP.
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Figure 52: Full H- H 2D TOCSY correlations and spectrum of G410. The bold bonds indicate
16H integrated into one large peak at 1.3 ppm.
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Figure 53: Full H- H 2D TOCSY correlations and spectrum of undecylprodiginine. The bold
bonds indicate 16H integrated into one large peak.
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The

production

of

2-hydroxyundecylprodiginine

(26),

a

straight

chain

undecylprodiginine analog by S. venezuelae JND2ΔG as a result of marG
deletion, indicates that MarG is required for the cyclization of the acyl chain of 2hydroxyundecylprodiginine with the reduction of the double bond at the methine
bridge connecting C-8 and C-9 (Figure 54). The absence of undecylprodiginine
(7) in this strain is inconsistent with the hypothesis (Figure 19), that MarG is
responsible for the introduction of the spiroaminal ring oxygen of marineosin. The
production of 2-hydroxyundecylprodiginine (26) suggests other possibilities
including (Figure 54):



A different substrate specificity of MarP, that leads to the incorporation of
a hydroxy-butyric acid starter unit in the acyl chain of 2-undecylpyrroline
subunit. Or,



An unknown hydroxylase enzyme, such as MarT or MarE (both annotated
as hypothetical proteins), is involved in the introduction of the hydroxyl
group to undecylprodiginine structure.
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Figure 54: Hypotheses explaining the biosynthesis of G410

3.4.1.2 The role of MarA in the biosynthesis of marineosin
3.4.1.2.1 Sequence analysis of marA
The marA gene is 468 bp, whose predicted protein sequence consists of 155
amino acids, corresponding to a calculated molecular weight of 16.07 kDa. An
NCBI BLAST search of MarA protein indicates that MarA has 56% identity to
MaoC-like dehydratase and 45% identity to enoyl-CoA hydratase, and
accordingly, MarA was provisioned as a putative dehydratase (Table 1). A
conserved domain data search of MarA primary protein sequence reveals that
MarA belongs to the HotDog superfamily of proteins which comprises a wide
range of enzymes with distinct catalytic activities such as dehydratases,
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thioesterases, dehydrogenases and acyltransferases. The primary protein
sequence of MarA suggests that it specifically belongs to the MaoC dehydrataselike HotDog subfamily which also includes the human β-hydroxysteroid
dehydrogenase and NodN, an enzyme involved in cell signaling of Rhizobium
roots [79].

Figure 55: Graphical summary of conserved domain hits obtained after NCBI CDD search.
The figure indicates that MarA belong to the HotDog superfamily of enzymes.

3.4.1.2.2 Targeted gene replacement of marA and the generation of S.
venezuelae JND2ΔA: A marA knockout strain
In Section 2.4.2, we proposed that the putative dehydratase, MarA catalyzes the
final spiroaminal ring formation of 2-hydroxyundecylprodiginine intermediate
(Figure 19). To test our hypothesis, marA gene in pMAR cosmid, was replaced
with a spectinomycin resistance marker gene, aadA. Gene replacement was
confirmed via PCR using primers designed to amplify the region flanking the
marA gene. The PCR of the mutant cosmid pMARΔA, a marA replacement
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mutant cosmid led to the amplification of ~ 1500 bp fragment corresponding to
aadA gene (1150 bp) plus the flanking 400 bp (lane ΔA, Figure 56). A PCR done
using the same primers but using pMAR cosmid, as a control led to the
amplification of a fragment of ~ 1000 bp, corresponding to marA gene (468 bp)
plus the flanking 400 bp (lane C, Figure 56). The mutant cosmid, pMARΔA was
delivered to wild type S. venezuelae via conjugation and the new strain was
named S. venezuelae JND2ΔA. The new strain is both apramycin and
spectinomycin resistant and is characterized by a faint red color when compared
to S. venezuelae JND2ΔG mutant strain.

Figure 56: Confirmation of marA replacement, from pMAR cosmid, with aadA gene
conferring resistance to spectinomycin antibiotic. Lane L = DNA ladder, lane C = a control
PCR reaction performed using pMAR cosmid, lane ΔA = PCR reaction performed using pMARΔA
cosmid.
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3.4.1.2.3 MS, LC/MS and LC-UV/MS analysis of S. venezuelae JND2ΔA
The MS profile of S. venezuelae JND2ΔA strain was monitored via
ThermoElectron LTQ-Orbitrap high resolution mass analyzer to determine the
main metabolites accumulated as a result of marA gene replacement. The MS
profile of the crude acetone extract of S. venezuelae JND2ΔA was compared to
that of the crude acetone extracts of S. venezuelae JND2 strain, marineosin

Relative Abundance

producer (Figure 57).
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Figure 57: Comparison between the MS profiles of S. venezuelae JND2ΔA (top panel), and
JND2 strain (bottom panel). MS profile of JNDΔA strain (top panel) shows two main compounds
with m/z 408.26 and 422.24 while the MS profile of JND2 strain shows the same two compounds,
to a much lower extent, and mainly marineosin, m/z 410.28.
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The MS profile of S. venezuelae JND2ΔA crude acetone extract is characterized
by the presence of two main signals with [M+H]+ m/z 408.27 and 422.24 that
were named JN408 and JN422, respectively. JN408 and JN422 were also found
in S. venezuelae JND2 control but to a much lower extent.
As observed for other JND2 engineered strains, the LC-UV/MS analysis of the
acetone extract of JND2ΔA indicates two groups of compounds (Figure 58). One
group has a λmax 320 nm which indicates non-conjugated, non-red compounds
and the other group has a λmax 530 nm which characterizes red-colored
prodiginine analogs. Marineosin production was not observed in this strain which
suggested that MarA is essential for the biosynthesis of marineosin.
Undecylprodiginine (7) production was also not observed in this strain which
suggests that undecylprodiginine (7) is either not an intermediate along the
pathway for the biosynthesis of marineosin, or does not accumulate in the mutant
because it gets hydroxylated very quickly by an unidentified oxidase.
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Figure 58: LC-UV/MS analysis of S. venezuelae JND2ΔA. Two groups of compounds exist: a
group with λmax 320 nm (green color) and a group with λmax 530 nm (magenta color).
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3.4.1.2.4 JN408 and JN422 are two marineosin analogs produced by S.
venezuelae JND2ΔA
As mentioned earlier, the deletion of marA from the marineosin gene cluster and
the generation of S. venezuelae JND2ΔA led to the accumulation of two major
compounds named JN408 (31) and JN422 (32) (Figure 59). Both compounds
were isolated from the acetone extract of S. venezuelae JND2ΔA after two
rounds of HPLC purifications to yield ~ 0.4 mg of JN408 and ~ 1 mg of JN422
(Figure 60). Detailed analysis of the MS, UV, IR and NMR spectral data of JN408
(31) indicated it to be an oxidized marineosin analog while analysis of JN422 (32)
data indicated it to be a 9-keto-derivative of JN408 (Figure 59).

Figure 59: Structures of JN408 and JN422, produced by S. venezuelae JND2ΔA
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Figure 60: HPLC chromatogram of purified JN408 (top panel) and purified JN422 (bottom
panel). The red trace represents absorption at λmax 530 nm and blue trace represents
absorption at λmax 320 nm.
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The UV spectrum of both JN408 (31) and JN422 (32) is characterized by λmax
320 nm similar to the UV spectrum of marineosin (Figure 61). This preliminary
data suggested that both compounds have a non-conjugated tri-pyrrole ring
system similar to marineosin.
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Figure 61: UV spectrum of JN408 (top panel) and JN422 (bottom panel)
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HR-ESI-MS analysis of JN408 (31) exhibits [M+H]+ of m/z 408.2660 (Figure 62).
The acquired mass was analyzed for molecular formula C25H34O2N3 or
C25H33O2N3 without the H-adduct. The difference between the mass acquired for
JN408 (31), and the mass of the predicted molecular formula is only m/z 0.0014
(Figure 63). The theoretical isotope pattern of the predicted molecular formula
was found to be identical to the isotope pattern acquired for JN408 (31). The
molecular formula C25H34O2N3 corresponds to an index of hydrogen deficiency of
11.
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Figure 62: HR-ESI-MS of JN408
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Figure 63: Comparison between the acquired mass and isotope pattern (top panel) and the
predicted mass (bottom panel) for JN408. There is a difference of m/z 0.0014 between the
acquired and predicted mass for JN408.

The MS/MS of JN408 (31) is characterized by the presence of daughter fragment
ions m/z 391.33 (33), and 376.33 (34) corresponding to the loss of m/z 17 and
32, respectively (Figure 64) (Figure 65). This profile is consistent with the loss of
a hydroxyl radical to generate fragment ion (33) followed by the loss of a methyl
radical to generate fragment ion (34) (Figure 65). The generation of m/z 230.25
(21) fragment ion was observed previously in the MS/MS profile of marineosin
(Figure 14) (Figure 15) which indicated that JN408 and marineosin share similar
structures. The neutral loss of m/z 15 characteristic for conjugated red-colored
prodiginines such as undecylprodiginine (7) (Figure 21) or G410 (27) (Figure 41),
was not observed in the MS/MS profile of JN408 which further corroborated a
structure similar to marineosin rather than undecylprodiginine (7) or G410 (27).
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JN408-2 #6-363 RT: 0.04-1.99 AV: 179 NL: 6.44E5
F: ITMS + p ESI Full ms2 408.26@cid20.00 [110.00-408.00]
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Figure 64: ESI-CID-MS profile of JN408. The MS/MS profile of JN408 is characterized by the
presence of m/z 230.25, 376.33 and 391.33 daughter ion fragments. Parent ion, m/z 408.26 is not
shown. Please refer to text for more details.
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Figure 65: Fragment ions observed in the MS/MS profile of JN408. The daughter fragment
m/z 230.19 was observed before in the MS/MS profile of marineosin which suggested that JN408
is a marineosin analog. The loss of m/z 17 from JN408, corresponding to the loss of a hydroxyl
radical leads to the generation of fragment (33). The consequent loss of a methyl radical from
fragment ion (33) leads to the generation of fragment ion (34). It should be noted that the masses
recorded in this figure are for the calculated values and are slightly different from the
experimentally acquired values shown in Figure 64.

The HR-ESI-MS analysis of JN422 (32) exhibits [M+H]+ of m/z 422.2450 (Figure
66). The acquired mass was analyzed for molecular formula C25H32O3N3 or
C25H31O3N3 without the H-adduct. This corresponds to an index of hydrogen
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deficiency of 12. The difference between the acquired mass of JN422 and the
theoretical mass of the predicted molecular formula is only m/z 0.0012 (Figure
67). From the molecular formula, it was proposed that JN422 is a keto-derivative
of JN408, but the position of that keto group was unclear.
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Figure 66: HR-ESI-MS of JN422
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Figure 67: Comparison between the acquired mass and isotope pattern (top panel) and the
predicted mass (bottom panel) for JN422. There is a difference of m/z 0.0012 between the
acquired and predicted mass for JN422.
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The MS/MS of JN422 (32) is characterized by the presence of daughter fragment
ions m/z 405.25 (36), and 390.33 (37) corresponding to the loss of m/z 17 and
32, respectively (Figure 68) (Figure 69). This profile is consistent with the loss of
a hydroxyl radical from JN422 to generate fragment ion (36) followed by the loss
of a methyl radical to generate fragment ion (37) (Figure 69). A daughter
fragment ion m/z 244.25 (35) is also observed in the MS/MS profile of JN422
which corresponds to the keto-derivative of fragment ion (21) observed in the
MS/MS profile of JN408 and marineosin (Figure 65) (Figure 15). From fragment
ion (35), we concluded that a keto group is present in the acyl chain of JN422. As
observed in JN408 (31), the MS/MS profile of JN422 (32) lacks any daughter
fragments representing a neutral loss of m/z 15 characteristic for conjugated
prodiginines and therefore, JN422 was proposed to be a keto-derivative of JN408
rather than undecylprodiginine (7).
JN422 #1-357 RT: 0.01-1.98 AV: 178 NL: 6.43E5
F: ITMS + p ESI Full ms2 422.24@cid20.00 [115.00-422.00]
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Figure 68: ESI-CID-MS profile of JN422. Parent ion, m/z 422.24 is not shown. Please refer to
text for more details.
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420

Figure 69: Fragment ions observed in the MS/MS profile of JN422. The daughter fragment
m/z 244.17 (34) is the keto-derivative of fragment ion (21) observed in the MS/MS profile of both
marineosin and JN408. The loss of m/z 17 from JN422, corresponding to the loss of a hydroxyl
radical leads to the generation of fragment 35. The consequent loss of a methyl radical from
fragment ion 35 leads to the generation of fragment ion 36. It should be noted that the masses
recorded in this figure are for the calculated values and are slightly different from the
experimentally acquired values shown in Figure 68.

121

The IR spectrum of JN408 (31) compound (Figure 70) has IR max 2925, 2855,
1617, 1427, 1363, 1349, 1270, 1222, 1119, 1059, 1031, 956, 771 and 712 cm -1.
JN422 (32) was found to have the same IR max (Figure 70) peaks as JN408 with
only minor differences in the max values of individual peaks. However, the IR
spectrum of JN422 is characterized by the presence of an additional
characteristic IR max peak at 1705 cm-1 corresponding to C=O stretch of a keto
group. This comparison between the IR spectra of JN408 and JN422 provided
additional evidence that both compounds are related and that the predominant
difference is the presence of a keto group in JN422.
All UV-profile, HR-ESI-MS, MS/MS profile and IR spectra of JN408 (31) and
JN422 (32) indicated that both compounds are marineosin analogs and that are
both compounds probably have the same structure except for the presence of an
extra keto group in the acyl chain of JN422 (32). Therefore, further NMR spectral
analyses of both compounds were done side by side. The structure of JN422
(32) was elucidated using 1H-NMR, 1H-1H 2D COSY, 1H-1H 2D TOCSY, 2D
HSQC and 2D HMBC experiments. Due to limited quantity of JN408 (31), some
cross peak correlations in the 2D HSQC and 2D HMBC spectra were not
determined and therefore, the missing correlations were deduced by comparison
to JN422 2D HSQC and 2D HMBC spectra.
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Figure 70: The IR spectrum of JN408 (top panel) and JN422 (bottom panel)
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1

H-NMR spectra of both JN408 and JN422 (Figure 71) (Figure 72) have 6 peaks

with chemical shifts, δ 5.5 - 7.5 ppm which indicates the presence of 6 aromatic
protons.
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Figure 71: H-NMR spectrum of JN408. Key protons peaks are assigned.
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Figure 72: H-NMR spectrum of JN422. Key protons are assigned.

The 13C-chemical shifts of JN408 (31) and JN422 (32) were indirectly determined
from the 2D HSQC (Figure 73) and 2D HSQCED spectra (Figure 74) of both
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molecules. The 2D HSQCED spectra of JN408 (31) and JN422 (32) confirmed
that the 6 protons with chemical shifts δ 5.5 – 7.5 ppm are attached to carbons
with

13

C-chemical shifts δ 93 – 131 ppm which is usually observed for carbons

part of an aromatic ring system. Detailed 1H- and

13

C-chemical shifts of JN408

and JN422 is presented in Table 15.
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Figure 73: 2D HSQC spectrum of JN408
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Figure 74: 2D HSQCED spectrum of JN408 (top panel) and JN422 (bottom panel). Key peak
assignments are indicated on spectra.
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Table 15: NMR Spectral data for JN408 and JN422 (600 MHz, Acetone-d6)

Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

a

JN408
δ Ha
7.37
6.37
7.08

JN422
δH
7.45
6.39
7.20

5.93

6.01

2.89

2.90

5.64
5.46

5.61
5.48

2.24, 2.37
1.37
1.34, 1.37
0.54, 0.80
1.42, 1.86
1.05, 1.20
1.00, 1.37
2.71
1.67, 1.91
4.36
1.50
3.99

2.37, 2.73
2.16, 3.05
1.71, 2.21
1.29, 1.31
0.94, 1.33
1.12, 1.26
2.80
1.67, 1.82
4.36
1.50
4.02

JN408
δCa
131.3
111.6
127.5
N.D.
N.D.
93.1
N.D.
N.D.
46.1
N.D.
109.0
104.5
N.D.
28.0
26.5
29.3
24.7
24.4
24.3
31.9
28.1
37.8
70.1
20.9
59.1

JN422
δC
131.5
112.4
125.9
N.D.
N.D.
93.1
180.6
97.4
46.3
125.7
108.3
105.5
130.1
23.6
39.9
211.3
43.6
29.4
22.1
24.7
27.3
37.9
70.0
20.6
59.4

1

Assignment by 1D ( H), and 2D (COSY, TOCSY, HSQC) NMR spectroscopy; N.D.: not
determined.
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1

H-1H 2D TOCSY (Figure 75) aromatic correlations among the 6 aromatic

protons observed in both JN408 (31) and JN422 (32) confirms that these protons
constitute the tripyrrole ring skeleton characteristic to prodiginines family of
natural products. The presence of 6 aromatic protons in JN408 and JN422 vs.
only 5 aromatic protons in marineosin suggested that the pyrrole ring B in JN408
(31) and JN422 (32) is oxidized and fully conjugated. It should be noted from
Table 15 and 1H-1H 2D TOCSY spectra (Figure 75) (Figure 76) of JN408 (30)
and JN422 (31), that both compounds are identical in their aromatic regions
represented by C1, C2, C3, C6, C11 and C12. Similar 2D TOCSY correlations
were observed for G410 (27) and undecylprodiginine (7) (Figure 46) which again
confirms that all three pyrrole rings of JN408 (31) and JN422 (32) are nonreduced, unlike that observed in marineosin.
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Figure 75: H- H 2D TOCSY spectrum of JN408. Top panel: JN408 showing selected H- H 2D
1
1
TOCSY correlations among aromatic protons only, shown in bold. Bottom panel: full H- H 2D
TOCSY spectrum of JN408 with the aromatic region correlations boxed and key correlations
assigned.
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Figure 76: H- H 2D TOCSY spectrum of JN422 showing correrlations between aromatic
1
1
protons. Top panel: selected H- H 2D TOCSY correlations of JN422 among aromatic protons, in
1
1
bold. Bottom panel: full H- H 2D TOCSY spectrum of JN422 with the aromatic region
correlations boxed and key correlations assigned.
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The 2D HSQCED of JN408 (31) indicated the presence of 8 methylene groups
(Figure 77) while that of JN422 (32) indicated the presence of only 7 methylene
groups (Figure 78).

C-18

C-19

C-17

C-15

C-14

C-16
C-20

C-22

Figure 77: 2D HSQCED spectrum of JN408 - aliphatic region expanded. Carbons bonding
even number of protons are shown in blue while carbons bonding odd number of protons are
shown in green. Aliphatic – CH2 groups are assigned and boxed. A total of 8 –CH2 groups are
present.
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C-20
C-14
C-19
C-18

C-22

C-15
C-17

Figure 78: 2D HSQCED spectrum of JN422 - aliphatic region expanded. Carbons bonding
even number of protons are shown in green while carbons bonding odd number of protons are
shown in blue. Aliphatic – CH2 groups are assigned and boxed. A total of 7 –CH2 groups are
present. A cross peak at (F1=1.12 ppm, F2=24.7 ppm), corresponding to the second proton
attached to C-20 is not shown in this spectrum.
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In JN422, 1H-1H 2D TOCSY correlations were found between protons at C9 and
C21 (Figure 79) which suggested that a covalent bond exists between C9 and
C21 to form a macrocyclic ring.
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Figure 79: Selected H- H 2D TOCSY correlations (top panel) and spectrum (bottom) of
JN422 - aliphatic region expanded. Correlations between protons at C9 and C21 and
neighboring –CH2 groups are represented by bold bonds in JN422 structure (top panel). The
same correlations are shown and boxed in the TOCSY spectrum (bottom panel).
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These data were confirmed by 2D HMBC correlations between protons at C9 and
C7, C8, C10, C11, C20, C21 and C22 (Figure 80).

H-9, C-21
H-9, C-22

H-9, C-8
H-9, C-11
H-9, C-10

H-9, C-7

H-17, C-16

1

13

Figure 80: Selected 2D HMBC ( H- C) correlation (top panel) and spectrum (bottom panel)
of JN422 - aliphatic region expanded. Correlations between proton at C9 and neighboring
carbons are represented by bold bonds in JN422 structure (top panel). Correlations between
protons at C-17 and the carbonyl carbon at C-16 are also in bold. The same correlations are
boxed and assigned in the 2D HMBC spectrum (bottom panel).
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The same clear correlations between proton at C9 and proton at C21 were
observed in the 1H-1H 2D TOCSY spectrum of JN408 (Figure 81).

9, 20a

21, 20a

9, 20b
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9, 22b
21, 22b
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1

1

Figure 81: Selected H- H 2D TOCSY correlations (top panel) and spectrum (bottom) of
JN408- aliphatic region expanded. Correlations between protons at C9 and C21 and
neighboring –CH2 groups are represented by bold bonds in JN408 structure (top panel). The
same correlations are boxed in the TOCSY spectrum (bottom panel). Key correlations for C9 and
C21 are indicated.
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Unfortunately, due to limited quantity of JN408 (31), these correlations could not
be confirmed by 2D HMBC data. However, the TOCSY data was sufficient to
conclude that JN408 has a macrocyclic ring similar to that present in JN422 (32)
and marineosin.
In JN422, weak (1H-13C) HMBC correlations (Figure 80) between a carbonyl
carbon at δ 211 ppm and protons at C17 suggested that the carbonyl group
observed in the IR spectrum of JN422 exists in the vicinity of C17. 1H-1H 2D
TOCSY spectrum of JN422 shows strong correlations between protons at C14
and C15 but these correlations are not extended to any other proton in the acyl
chain of JN422, suggesting that C15 is next to either a heteroatom or a
quaternary carbon. Also, protons at C15 and C17 in JN422 (32) are slightly
shifted downfield relative to their counterparts in JN408 (31) (Table 15).
Therefore, we assigned the position of the keto group of JN422 (32) at C16.
Since all protons were accounted for except the protons at C8 and C23, we
concluded that a spiroaminal ring exists between C8 and C23 in both JN408 (31)
and JN422 (32).
Full spectral data and correlations of JN408 (31) and JN422 (32) are presented
in Figure 83, Figure 84, Figure 85, Figure 86, Figure 87, Table 16, Table 17, and
Table 18.
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Figure 82: H- H 2D TOCSY spectrum of JN422 showing correlations between C14 and
C15. Correlations between protons at C14 and C15 are indicated. The correlations are not
extended to neighboring –CH2 groups in the TOCSY spectrum indicating that both groups are
either adjacent to a heteroatom or a quaternary carbon.
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A)

B)

1

1

Figure 83: A) H- H 2D COSY correlations of JN408. B) 2D COSY NMR spectrum of JN422.
Selected COSY correlations in JN408 are drawn in bold.
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A)

B)

Figure 84: A) Selected COSY (H↔H; bold lines) and TOCSY (H↔H; double arrows) NMR
correlations for JN408. B) 2D TOCSY NMR spectrum of JN408.
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Position
1
2
3
4
5
6
7
8
9

δH
7.37
6.37
7.08

COSY
2, 3
1, 3
1, 2

TOCSY
2, 3
1, 3
1, 2

2.89

21

20, 21, 22, 23,
24

5.93

10
11
12
13
14
15
16

5.64
5.46

12
11

12
11

2.24, 2.37
1.37
1.34, 1.37

15
14, 17
15, 18

17

0.54, 0.80

16, 18

18

1.42, 1.86

17, 19

19

1.05, 1.20

18, 20

20

1.00, 1.37

19, 21

21

2.71

9, 20, 22

22

1.67, 1.91

21, 23

23

4.36

22, 24

24
25

1.50
3.99

23

15, 16, 17
14, 16, 17, 18
14, 15, 17, 18,
19
15, 16, 18, 19,
20
15, 16, 17, 19,
20
16, 17, 18, 20,
21
9, 17, 18, 19,
21, 22
9, 19, 20, 22,
23, 24
9, 20, 21, 23,
24
9, 20, 21, 22,
24
9, 21, 22, 23

Table 16: Selected COSY (H↔H) and TOCSY (H↔H) NMR correlations for JN408
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A)

B)

Figure 85: A) 1H-1H 2D COSY correlations of JN422. B) 2D COSY NMR spectrum of JN422.
Selected COSY correlations in JN422 are drawn in bold.
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A)

B)

Figure 86: A) Selected COSY (H↔H; bold lines) and TOCSY (H↔H; double arrows) NMR
correlations for JN422. B) 2D TOCSY NMR spectrum of JN422.
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A)

B)

Figure 87: A) Selected HMBC (1H→13C) NMR correlations for JN422. B) 2D HMBC
spectrum of JN422.
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Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

δH
7.45
6.39
7.20

COSY
2, 3
1, 3
1, 2

TOCSY
2, 3
1, 3
1, 2

2.90

21

20, 21, 22, 23, 24

5.61
5.48

12
11

12
11

2.37, 2.73
2.16, 3.05

15
14

15
14

1.71, 2.21
1.29, 1.31
0.94, 1.33
1.12, 1.26
2.80
1.67, 1.82
4.36
1.50
4.02

18
17, 19
18, 20
19, 21
9, 20, 22
21, 23
22, 24
23

18, 19, 20
17, 19, 20
17, 18, 20, 21
9, 17, 18, 19, 21, 22
9, 19, 20, 22, 23, 24
9, 20, 21, 23, 24
9, 20, 21, 22, 24
9, 21, 22, 23

6.01

Table 17: Selected COSY (H↔H) and TOCSY (H↔H) NMR correlations for JN422
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Position

δ Ha

δCa

1
2

7.45
6.39

131.5
112.4

CH
CH

3
4
5
6
7
8

7.20

125.9
N.D.
N.D.
93.1
180.6
97.4

CH
C
C
CH
C
C

9
10
11
12
13
14
15

2.90

2.37, 2.73
2.16, 3.05

46.3
125.7
108.3
105.5
130.1
23.6
39.9

CH
C
CH
CH
C
CH2
CH2

16
17
18
19
20
21

1.71, 2.21
1.29, 1.31
0.94, 1.33
1.12, 1.26
2.80

211.3
43.6
29.4
22.1
34.7
27.3

C=O
CH2
CH2
CH2
CH2
CH

22
23
24
25

1.67, 1.82
4.36
1.50
4.02

37.9
70.0
20.6
59.4

CH2
CH
CH3
CH3

6.01

5.61
5.48

Selected HMBC correlations

7, 8, 10, 11, 20, 21, 22
10, 12, 13
10, 13
12, 13, 15, 16

16, 19
19, 20
18
9

22, 23
7

Table 18: NMR Spectral data for JN422 (600 MHz, Acetone-d6) and Selected HMBC
correlations.
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3.5 CONCLUSIONS
From the structures of JN408 (31) and JN422 (32), it is evident that MarA does
not catalyze spiroaminal ring formation because its deletion led to the
accumulation of two spiroaminal marineosin analogs. Although an NADH/NADPH
binding site could not be identified from the primary protein sequence of MarA,
our data suggests that MarA acts as a dehydrogenase/reductase that is involved
in the reduction of pyrrole ring B of JN408 (31) to yield marineosins. We are
proposing that spiroaminal ring formation is either catalyzed by MarG or occurs
non-enzymatically via a concerted mechanism. In the latter case, the lone pair of
electrons of the –OH group of 2-hydroxyundecylprodiginine, G410 (27)
undergoes a nucleophilic attack on C-8, with the subsequent reduction of the
methine bridge between C-8 and C-9 (Figure 88). The –OH group of G410 (27)
can be introduced either early in the pathway due to the hydroxylation of 2-UP
subunit by an unidentified oxidase (route 1, Figure 88), or the recruitment of
hydroxy-butyric acid starter unit by MarP (route 2, Figure 88). The hydroxyl group
can be also introduced later in the pathway, due to the presence of an
unidentified Mar protein that catalyzes the hydroxylation of undecylprodiginine (7)
such as MarT (route 3, Figure 88). The fact that undecylprodiginine (7)
intermediate was never detected in any of the strains generated in this study
suggests that route 1 or route 2 of our hypothesis are the most likely ones to be
correct. Primary protein sequence analysis of MarT and other hypothetical
proteins encoded by the mar gene cluster does not show any similarity to known
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p450 oxidases, or non-heme iron Rieske oxygenases. Moreover, homologs of
MarT and other hypothetical Mar proteins are also encoded by the red gene
cluster but no hydroxylated undecylprodiginine was ever reported before, which
makes route 3 of our hypothesis less plausible. We are proposing that JN422
(32) is a shunt metabolite generated from the introduction of a keto group to
either JN408 (31), or very early in the pathway due to incorporation of a ketobutyric acid starter unit, or a modified specificity of the fatty acid synthases
involved in the biosynthesis of the acyl side chain of marineosin (Figure 88). To
the best of our knowledge, JN422 (32) is the first isolated cyclic prodiginine
analog with a keto group in the ansa-bridged macrocycle and studying the
biological activity of this compound would be very interesting.

148

Figure 88: Scheme for the biosynthesis of marineosin. Isolated metabolites are boxed.
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4. Conclusions and future work recommendations
The work presented in this dissertation describes the biosynthesis of marineosin,
a novel prodiginine analog and how it differs from the biosynthesis of other
prodiginines compounds directed by the red gene cluster. It also provides
valuable insights into the in vivo role of two key enzymes involved in the
biosynthesis of marineosin and proposes an experimentally-supported scheme
describing the key steps en route to marineosin.
The present study paves the way to the targeted biosynthesis of a valuable
combinatorial library of marineosin and prodiginine analogs and opens up a
treasure of research opportunities.

Conclusion 1: Marineosin biosynthesis is directed by a red gene cluster
homolog named, mar gene cluster; with the presence of only one extra gene
encoding a putative dehydrogenase/reductase named MarA.

No additional

tailoring enzymes are involved in the biosynthesis of marineosin.

Conclusion 2: MarG, a non-heme iron Rieske-oxygenase catalyzes the
oxidative cyclization of the acyl chain of 2-hydroxyundecylprodiginine (27) with
the subsequent formation of an ansa-bridged 12-membered carbocyclic ring.
MarG does not catalyze the introduction of the –OH group required to initiate the
biosynthesis of the spiroaminal ring of marineosin. Undecylprodiginine (7) is not a
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detectable intermediate along the biosynthetic route to marineosin. The reduction
of pyrrole ring B happens later in the pathway, after MarG catalysis step.

Conclusion 3: MarA, a putative dehydrogenase/reductase catalyzes the
reduction of pyrrole ring B of JN408 (31) intermediate to generate marineosin.
MarA is not involved in neither the introduction of the –OH group of 2hydroxyundecylprodiginine (27) nor the biosynthesis of the spiroaminal ring.
Deletion of marA gene leads to the accumulation of a novel marineosin analog.

Conclusion 4: The origin of the spiroaminal ring oxygen is probably due to a
different substrate specificity of MarP; the first enzyme involved in the
biosynthesis of the acyl chain of marineosin or, an unidentified oxidase that
hydroxylates the acyl chain of undecylprodiginine (7).

Conclusion 5: The first experimentally-supported scheme describing the
biosynthesis of marineosin was presented.

Future work:
1. The substrate specificity and mechanism of action of MarG enzyme can be
studied after its expression and purification. MarG belongs to a class of Rieske
oxygenases whose function is still not fully understood and its characterization
could provide a wealth of information on C-H bond activation.
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2. The exact function of MarA enzyme can be only be verified through detailed
kinetic analysis following its expression as a recombinant protein. The substrate
specificity of MarA can be determined by testing its reductase activity with
several natural and synthetic, straight chain and cyclic prodiginine analogs.

3. The exact origin of the spiroaminal ring oxygen can be pinned down through
the feeding of isotope-labeled hydroxyl-butyric acid starter unit to S. venezuelae
JND2ΔG followed by purification and characterization of isotope labeling patterns
of the generated 2-hydroxyundecylprodiginine. Also, the deletion of MarTencoding gene from the mar gene cluster can be used to study whether or not it
plays a critical role in the biosynthesis of marineosin.
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